http://fasb.org/us-gaap/2024#RelatedPartyMember2180268921802689http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://cfacquisitioncorpviii.com/20240930#SellingGeneralAndAdministrativeExpenseExcludingDepreciationDepletionAndAmortization0001839530--12-312024Q3003016610230166102http://fasb.org/us-gaap/2024#RelatedPartyMemberP3MP1YP1YP1Yhttp://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNethttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#DefinedBenefitPlanActuarialGainLosshttp://fasb.org/us-gaap/2024#FairValueAdjustmentOfWarrants030166102http://cfacquisitioncorpviii.com/20240930#SellingGeneralAndAdministrativeExpenseExcludingDepreciationDepletionAndAmortizationP1YP1YP10Yhttp://fasb.org/us-gaap/2024#RelatedPartyMemberhttp://fasb.org/us-gaap/2024#RelatedPartyMemberhttp://fasb.org/us-gaap/2024#RelatedPartyMemberhttp://fasb.org/us-gaap/2024#RelatedPartyMemberfalse0001839530xbp:U.k.PensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530xbp:NorwayPensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530xbp:GermanPensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530xbp:AsterionPensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2023-09-152023-09-150001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2023-09-042023-09-040001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2023-03-310001839530us-gaap:RelatedPartyMember2016-01-012016-01-010001839530xbp:AmendedFactoringAgreementMember2023-09-150001839530xbp:RevolvingCreditFacility2024Memberxbp:FacilitiesAgreement2024Member2024-06-012024-06-300001839530srt:MinimumMemberxbp:U.k.PensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530srt:MaximumMemberxbp:U.k.PensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2010-05-310001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2009-09-300001839530xbp:SecuredBorrowingFacilityMember2020-08-252020-08-250001839530xbp:PublicWarrantsMember2024-01-012024-09-300001839530srt:MinimumMemberxbp:FacilitiesAgreement2024Member2024-06-300001839530srt:MaximumMemberxbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Member2024-01-012024-09-300001839530srt:MaximumMemberxbp:CreditAgreement2019Member2024-01-012024-09-300001839530srt:MaximumMemberxbp:CreditAgreement2019And2020CreditAgreementMember2024-01-012024-09-300001839530xbp:PrivateWarrantsMemberus-gaap:FairValueInputsLevel3Member2024-09-300001839530xbp:PrivateWarrantsMemberus-gaap:FairValueInputsLevel3Member2023-12-310001839530us-gaap:RetainedEarningsMember2024-09-300001839530us-gaap:AdditionalPaidInCapitalMember2024-09-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-09-300001839530us-gaap:RetainedEarningsMember2024-06-300001839530us-gaap:AdditionalPaidInCapitalMember2024-06-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-06-3000018395302024-06-300001839530us-gaap:RetainedEarningsMember2024-03-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-03-3100018395302024-03-310001839530us-gaap:RetainedEarningsMember2023-12-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-12-310001839530xbp:NetParentInvestmentMember2023-09-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-09-300001839530xbp:NetParentInvestmentMember2023-06-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-06-3000018395302023-06-300001839530xbp:NetParentInvestmentMember2023-03-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-03-3100018395302023-03-310001839530xbp:NetParentInvestmentMember2022-12-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-12-310001839530us-gaap:EmployeeStockOptionMember2024-09-300001839530xbp:StockIncentivePlan2024Member2024-06-130001839530us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001839530us-gaap:RestrictedStockUnitsRSUMember2024-09-300001839530us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001839530srt:MinimumMemberus-gaap:EmployeeStockOptionMember2024-01-012024-09-300001839530srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-3000018395302027-01-012024-09-3000018395302026-01-012024-09-3000018395302025-01-012024-09-3000018395302024-10-012024-09-300001839530srt:MaximumMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530xbp:OtherCountriesMember2024-07-012024-09-300001839530country:SE2024-07-012024-09-300001839530country:GB2024-07-012024-09-300001839530country:FR2024-07-012024-09-300001839530country:DE2024-07-012024-09-300001839530xbp:OtherCountriesMember2024-01-012024-09-300001839530country:SE2024-01-012024-09-300001839530country:GB2024-01-012024-09-300001839530country:FR2024-01-012024-09-300001839530country:DE2024-01-012024-09-300001839530xbp:OtherCountriesMember2023-07-012023-09-300001839530country:SE2023-07-012023-09-300001839530country:GB2023-07-012023-09-300001839530country:FR2023-07-012023-09-300001839530country:DE2023-07-012023-09-300001839530xbp:OtherCountriesMember2023-01-012023-09-300001839530country:SE2023-01-012023-09-300001839530country:GB2023-01-012023-09-300001839530country:FR2023-01-012023-09-300001839530country:DE2023-01-012023-09-300001839530xbp:TermLoanMemberxbp:CommittedFacilityAgreement2022Member2024-01-012024-09-300001839530xbp:SecuredTermLoanMemberxbp:CreditAgreement2019Member2024-01-012024-09-300001839530xbp:SecuredTermBLoanMemberxbp:CreditAgreement2019Member2024-01-012024-09-300001839530xbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Member2024-01-012024-09-300001839530us-gaap:RevolvingCreditFacilityMemberxbp:CreditAgreement2019Member2024-01-012024-09-300001839530xbp:CreditAgreement2020Member2024-01-012024-09-300001839530xbp:CreditAgreement2019Member2024-01-012024-09-300001839530xbp:CommittedFacilityAgreement2022Member2024-01-012024-09-300001839530srt:MaximumMemberxbp:FacilitiesAgreement2024Member2024-06-300001839530srt:MinimumMemberxbp:ComputerEquipmentAndSoftwareMember2024-09-300001839530srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2024-09-300001839530srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2024-09-300001839530srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-09-300001839530srt:MaximumMemberxbp:ComputerEquipmentAndSoftwareMember2024-09-300001839530srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2024-09-300001839530srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2024-09-300001839530srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2024-09-300001839530xbp:ComputerEquipmentAndSoftwareMember2024-09-300001839530us-gaap:MachineryAndEquipmentMember2024-09-300001839530us-gaap:LeaseholdImprovementsMember2024-09-300001839530us-gaap:FurnitureAndFixturesMember2024-09-300001839530us-gaap:BuildingAndBuildingImprovementsMember2024-09-300001839530xbp:ComputerEquipmentAndSoftwareMember2023-12-310001839530us-gaap:MachineryAndEquipmentMember2023-12-310001839530us-gaap:LeaseholdImprovementsMember2023-12-310001839530us-gaap:FurnitureAndFixturesMember2023-12-310001839530us-gaap:BuildingAndBuildingImprovementsMember2023-12-310001839530xbp:RevolvingCreditFacility2024Memberxbp:FacilitiesAgreement2024Member2024-01-012024-09-300001839530xbp:TermLoanBFacility2024Member2024-01-012024-09-300001839530xbp:TermLoanaFacility2024Member2024-01-012024-09-300001839530xbp:RevolvingCreditFacility2024Member2024-01-012024-09-300001839530xbp:SecuredBorrowingFacilityMember2024-09-300001839530xbp:SecuredBorrowingFacilityMember2023-12-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-07-012024-09-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-04-012024-06-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-03-310001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-07-012023-09-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-04-012023-06-300001839530us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-03-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-04-012023-06-300001839530us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310001839530xbp:SharedServicesMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530xbp:ServiceFeeMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530us-gaap:RoyaltyMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530xbp:SharedServicesMember2024-07-012024-09-300001839530xbp:ServiceFeeMember2024-07-012024-09-300001839530xbp:SharedServicesMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530xbp:ServiceFeeMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530us-gaap:RoyaltyMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530xbp:SharedServicesMember2024-01-012024-09-300001839530xbp:ServiceFeeMember2024-01-012024-09-300001839530xbp:SharedServicesMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001839530xbp:ServiceFeeMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001839530us-gaap:RoyaltyMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001839530xbp:SharedServicesMember2023-07-012023-09-300001839530xbp:ServiceFeeMember2023-07-012023-09-300001839530us-gaap:RoyaltyMember2023-07-012023-09-300001839530xbp:SharedServicesMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001839530xbp:ServiceFeeMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001839530us-gaap:RoyaltyMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001839530xbp:SharedServicesMember2023-01-012023-09-300001839530xbp:ServiceFeeMember2023-01-012023-09-300001839530us-gaap:RoyaltyMember2023-01-012023-09-300001839530us-gaap:RetainedEarningsMember2024-07-012024-09-300001839530us-gaap:RetainedEarningsMember2024-04-012024-06-300001839530us-gaap:RetainedEarningsMember2024-01-012024-03-310001839530xbp:NetParentInvestmentMember2023-07-012023-09-300001839530xbp:NetParentInvestmentMember2023-04-012023-06-3000018395302023-04-012023-06-300001839530xbp:NetParentInvestmentMember2023-01-012023-03-3100018395302023-01-012023-03-310001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2020-04-012020-04-300001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2023-03-012023-03-310001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2023-11-102023-11-100001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2024-01-012024-09-300001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2023-05-092023-05-090001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2024-09-300001839530xbp:ClaimBroughtByFormerEmployeesForTheirDismissalMember2023-12-310001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2024-09-300001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2023-12-310001839530xbp:WorkingCapitalLoanMember2024-09-300001839530us-gaap:RevolvingCreditFacilityMember2024-09-300001839530xbp:WorkingCapitalLoanMember2023-12-310001839530xbp:TermLoanMember2023-12-310001839530us-gaap:SecuredDebtMember2023-12-310001839530us-gaap:RevolvingCreditFacilityMember2023-12-310001839530xbp:TermLoanBFacility2024Memberxbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:TermLoanaFacility2024Memberxbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:TermLoanBFacility2024Memberxbp:FacilitiesAgreement2024Member2024-01-012024-09-300001839530xbp:TermLoanaFacility2024Memberxbp:FacilitiesAgreement2024Member2024-01-012024-09-300001839530xbp:TermLoanBFacility2024Memberxbp:FacilitiesAgreement2024Member2024-06-300001839530xbp:TermLoanaFacility2024Memberxbp:FacilitiesAgreement2024Member2024-06-300001839530xbp:SecuredTermaLoanAndRevolvingCreditFacilityMemberxbp:FacilitiesAgreement2024Member2024-06-300001839530xbp:RevolvingCreditFacility2024Memberxbp:FacilitiesAgreement2024Member2024-06-300001839530xbp:TermLoanMemberxbp:CommittedFacilityAgreement2022Member2022-05-310001839530xbp:SecuredBorrowingFacilityMember2020-08-250001839530us-gaap:SecuredDebtMemberxbp:CreditAgreement2019Member2019-10-310001839530xbp:RevolvingCreditFacility2024Memberxbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:SecuredTermLoanMemberxbp:CreditAgreement2019Member2023-12-310001839530xbp:SecuredTermBLoanMemberxbp:CreditAgreement2019Member2023-12-310001839530xbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Member2023-12-310001839530us-gaap:RevolvingCreditFacilityMemberxbp:CreditAgreement2019Member2023-12-310001839530xbp:CommittedFacilityAgreement2022Member2023-12-310001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001839530xbp:SecuredBorrowingFacilityMember2024-07-012024-09-300001839530xbp:SecuredBorrowingFacilityMember2024-01-012024-09-300001839530xbp:SecuredBorrowingFacilityMember2023-07-012023-09-300001839530xbp:SecuredBorrowingFacilityMember2023-01-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:TechnologyBusinessUnitMember2024-07-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:BillsAndPaymentBusinessUnitMember2024-07-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:TechnologyBusinessUnitMember2024-01-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:BillsAndPaymentBusinessUnitMember2024-01-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:TechnologyBusinessUnitMember2023-07-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:BillsAndPaymentBusinessUnitMember2023-07-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:TechnologyBusinessUnitMember2023-01-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:BillsAndPaymentBusinessUnitMember2023-01-012023-09-300001839530xbp:TechnologyMember2024-01-012024-09-300001839530xbp:BillsAndPaymentsMember2024-01-012024-09-300001839530xbp:TechnologyMember2023-01-012023-12-310001839530xbp:BillsAndPaymentsMember2023-01-012023-12-310001839530xbp:TechnologyMember2024-09-300001839530xbp:BillsAndPaymentsMember2024-09-300001839530xbp:TechnologyMember2023-12-310001839530xbp:BillsAndPaymentsMember2023-12-310001839530xbp:TechnologyMember2022-12-310001839530xbp:BillsAndPaymentsMember2022-12-310001839530xbp:AmendedFactoringAgreementMember2024-07-012024-09-300001839530xbp:AmendedFactoringAgreementMember2024-01-012024-09-300001839530us-gaap:SoftwareDevelopmentMember2024-09-300001839530us-gaap:CustomerRelationshipsMember2024-09-300001839530us-gaap:ContractBasedIntangibleAssetsMember2024-09-300001839530us-gaap:CustomerRelationshipsMember2023-12-310001839530us-gaap:ContractBasedIntangibleAssetsMember2023-12-310001839530xbp:PrivateWarrantsMember2023-12-310001839530xbp:PrivateWarrantsMember2024-01-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:NonrelatedPartyMember2024-07-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:NonrelatedPartyMember2024-01-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:NonrelatedPartyMember2023-07-012023-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:NonrelatedPartyMember2023-01-012023-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMemberus-gaap:NonrelatedPartyMember2023-12-310001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2024-07-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2023-07-012023-09-300001839530xbp:GermanPensionPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-09-300001839530us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001839530us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001839530us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001839530us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-3000018395302023-01-012023-12-310001839530xbp:TermLoanBFacility2024Memberxbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:TermLoanaFacility2024Memberxbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:RevolvingCreditFacility2024Member2024-09-300001839530xbp:FacilitiesAgreement2024Member2024-09-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2012-12-310001839530srt:MinimumMemberxbp:SecuredBorrowingFacilityMember2020-08-250001839530xbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Member2020-06-300001839530xbp:SecuredTermLoanMemberxbp:CreditAgreement2019Member2019-10-310001839530xbp:SecuredTermBLoanMemberxbp:CreditAgreement2019Member2019-10-310001839530us-gaap:RevolvingCreditFacilityMemberxbp:CreditAgreement2019Member2019-10-310001839530xbp:TermLoanBFacility2024Memberxbp:FacilitiesAgreement2024Memberxbp:EuroInterbankOfferedRateMember2024-06-012024-06-300001839530xbp:TermLoanaFacility2024Memberxbp:FacilitiesAgreement2024Memberxbp:SterlingOvernightIndexAverageMember2024-06-012024-06-300001839530xbp:RevolvingCreditFacility2024Memberxbp:FacilitiesAgreement2024Memberxbp:ReferenceRateMember2024-06-012024-06-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530xbp:NewRelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001839530xbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Memberxbp:SterlingOvernightIndexAverageMember2023-03-312023-03-310001839530xbp:TermLoanMemberxbp:CommittedFacilityAgreement2022Memberus-gaap:BaseRateMember2022-05-012022-05-310001839530xbp:SecuredTermLoanMemberxbp:CreditAgreement2019Memberxbp:SterlingOvernightIndexAverageMember2021-12-312021-12-310001839530xbp:SecuredTermBLoanMemberxbp:CreditAgreement2019Memberxbp:SterlingOvernightIndexAverageMember2021-12-312021-12-310001839530us-gaap:RevolvingCreditFacilityMemberxbp:CreditAgreement2019Memberxbp:SterlingOvernightIndexAverageMember2021-10-292021-10-290001839530xbp:SecuredBorrowingFacilityMemberus-gaap:EurodollarMember2020-08-252020-08-250001839530xbp:RevolvingWorkingCapitalLoanFacilityMemberxbp:CreditAgreement2020Memberxbp:LondonInterBankOfferedRateMember2020-06-012020-06-300001839530xbp:SecuredTermLoanMemberxbp:CreditAgreement2019Memberxbp:LondonInterBankOfferedRateMember2019-10-012019-10-310001839530xbp:SecuredTermBLoanMemberxbp:CreditAgreement2019Memberxbp:LondonInterBankOfferedRateMember2019-10-012019-10-310001839530us-gaap:RevolvingCreditFacilityMemberxbp:CreditAgreement2019Memberxbp:LondonInterBankOfferedRateMember2019-10-012019-10-310001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2014-01-012024-09-300001839530xbp:RelatedPartyNotesPayableMemberus-gaap:RelatedPartyMember2013-01-012013-12-310001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:TechnologyBusinessUnitMember2024-07-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:BillsAndPaymentBusinessUnitMember2024-07-012024-09-300001839530xbp:RelatedAndNonRelatedPartyMember2024-07-012024-09-300001839530us-gaap:RelatedPartyMember2024-07-012024-09-300001839530us-gaap:NonrelatedPartyMember2024-07-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:TechnologyBusinessUnitMember2024-01-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:BillsAndPaymentBusinessUnitMember2024-01-012024-09-300001839530xbp:RelatedAndNonRelatedPartyMember2024-01-012024-09-300001839530us-gaap:RelatedPartyMember2024-01-012024-09-300001839530us-gaap:NonrelatedPartyMember2024-01-012024-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:TechnologyBusinessUnitMember2023-07-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:BillsAndPaymentBusinessUnitMember2023-07-012023-09-300001839530xbp:RelatedAndNonRelatedPartyMember2023-07-012023-09-300001839530us-gaap:RelatedPartyMember2023-07-012023-09-300001839530us-gaap:NonrelatedPartyMember2023-07-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:TechnologyBusinessUnitMember2023-01-012023-09-300001839530us-gaap:OperatingSegmentsMemberxbp:RelatedAndNonRelatedPartyMemberxbp:BillsAndPaymentBusinessUnitMember2023-01-012023-09-300001839530xbp:RelatedAndNonRelatedPartyMember2023-01-012023-09-300001839530us-gaap:RelatedPartyMember2023-01-012023-09-300001839530us-gaap:NonrelatedPartyMember2023-01-012023-09-300001839530us-gaap:CommonStockMember2024-09-300001839530us-gaap:CommonStockMember2024-06-300001839530us-gaap:CommonStockMember2024-03-310001839530us-gaap:CommonStockMember2023-12-310001839530xbp:PrivateWarrantsMember2024-09-300001839530xbp:PublicWarrantsMember2024-09-300001839530xbp:PrivatePlacementWarrantsMember2024-09-300001839530xbp:ForwardsPurchaseWarrantsMember2024-09-3000018395302023-09-3000018395302022-12-310001839530xbp:CfAcquisitionCorp.ViiiMember2023-11-292023-11-290001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2024-01-012024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2023-01-012023-09-300001839530xbp:CfAcquisitionCorp.ViiiMember2023-01-012023-12-310001839530xbp:CfAcquisitionCorp.ViiiMember2023-12-310001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2024-09-300001839530us-gaap:DiscontinuedOperationsHeldforsaleMemberxbp:DrescherGroupMember2023-12-310001839530us-gaap:WarrantMember2024-07-012024-09-300001839530xbp:RestrictedStockUnitsAndOptionsMember2024-01-012024-09-300001839530us-gaap:WarrantMember2024-01-012024-09-3000018395302023-07-012023-09-3000018395302023-01-012023-09-300001839530us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001839530us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001839530us-gaap:UnbilledRevenuesMember2024-09-300001839530us-gaap:BilledRevenuesMember2024-09-300001839530us-gaap:UnbilledRevenuesMember2023-12-310001839530us-gaap:BilledRevenuesMember2023-12-310001839530us-gaap:RelatedPartyMember2024-09-3000018395302024-09-300001839530us-gaap:RelatedPartyMember2023-12-3100018395302023-12-3100018395302024-07-012024-09-3000018395302024-04-012024-06-3000018395302024-01-012024-03-310001839530xbp:RedeemableWarrantsMember2024-01-012024-09-300001839530us-gaap:CommonStockMember2024-01-012024-09-3000018395302024-11-0600018395302024-01-012024-09-30xbp:Dxbp:Votexbp:itemxbp:installmentxbp:clientxbp:claimxbp:loanxbp:locationxbp:subsidiaryxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:GBPiso4217:EURxbp:employeexbp:countryxbp:segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the period ended September 30, 2024

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                   to

Commission File Number: 001-40206

XBP Europe Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

    

85-2002883

(State of or other Jurisdiction
Incorporation or Organization)

(I.R.S. Employer
Identification No.)

2701 East Grauwyler Road
Irving, Texas

75061

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (844) 935-2832

Securities Registered Pursuant to Section 12(b) of the Act:

Title of Each Class

    

Trading Symbol

     

Name of Each Exchange On Which Registered

Common Stock, Par Value $0.0001 per share

XBP

The Nasdaq Global Market

Redeemable warrants, each whole warrant exercisable for one
share of common stock at an exercise price of $11.50

XBPEW

The Nasdaq Capital Market

Indicate by check mark whether the Registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes No

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes  No

As of November 6, 2024, the Registrant had 30,166,102 shares of common stock outstanding.

TABLE OF CONTENTS

Item 1. Financial Statements

Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023 (Unaudited)

3

Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (Unaudited)

4

Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2024 and 2023 (Unaudited)

5

Condensed Consolidated Statements of Stockholders’ Deficit for the three and nine months ended September 30, 2024 and 2023 (Unaudited)

6

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (Unaudited)

8

Notes to the Condensed Consolidated Financial Statements (Unaudited)

9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

36

Item 3. Quantitative and Qualitative Disclosures about Market Risk

53

Item 4. Controls and Procedures

53

PART II — OTHER INFORMATION

54

Item 1. Legal Proceedings

54

Item 1A. Risk Factors

54

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds, and Issuer Purchases of Equity Securities

55

Item 3. Defaults Upon Senior Securities

55

Item 4. Mine Safety Disclosures

55

Item 5. Other Information

55

Item 6. Exhibits

56

Signatures

57

2

XBP Europe Holdings, Inc.

Condensed Consolidated Balance Sheets

As of September 30, 2024 and December 31, 2023

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

September 30, 

December 31, 

    

2024

    

2023

ASSETS

 

  

 

  

Current assets

 

  

 

  

Cash and cash equivalents

$

7,770

$

6,537

Accounts receivable, net of allowance for credit losses of $1,435 and $1,183, respectively

 

24,576

 

30,238

Inventories, net

 

4,056

 

4,045

Prepaid expenses and other current assets

 

6,912

 

6,550

Current assets held for sale

 

4,197

 

2,497

Total current assets

 

47,511

 

49,867

Property, plant and equipment, net of accumulated depreciation of $42,707 and $39,876, respectively

 

12,284

 

12,811

Operating lease right-of-use assets, net

 

6,726

 

5,206

Goodwill

 

23,281

 

22,823

Intangible assets, net

 

1,274

 

1,498

Deferred income tax assets

 

7,689

 

6,811

Other noncurrent assets

882

705

Noncurrent assets held for sale

 

 

3,018

Total assets

$

99,647

$

102,739

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

  

 

  

LIABILITIES

 

  

 

  

Current liabilities

 

  

 

  

Accounts payable

$

11,271

$

13,281

Related party payables

 

5,523

 

13,350

Accrued liabilities

 

22,152

 

23,850

Accrued compensation and benefits

 

16,623

 

16,268

Customer deposits

 

723

 

323

Deferred revenue

 

6,500

 

6,004

Current portion of finance lease liabilities

 

26

 

91

Current portion of operating lease liabilities

 

2,118

 

1,562

Current portion of long-term debts

5,047

3,863

Current liabilities held for sale

 

4,529

 

3,479

Total current liabilities

 

74,512

 

82,071

Related party notes payable

 

1,559

 

1,542

Long-term debt, net of current maturities

 

26,406

 

12,763

Finance lease liabilities, net of current portion

 

 

23

Pension liabilities

 

11,430

 

12,208

Operating lease liabilities, net of current portion

 

4,781

 

3,785

Other long-term liabilities

1,720

1,635

Noncurrent liabilities held for sale

 

 

1,280

Total liabilities

$

120,408

$

115,307

Commitments and Contingencies (Note 13)

 

  

 

  

STOCKHOLDERS’ DEFICIT

 

  

 

  

Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized; none issued and outstanding as of September 30, 2024 and December 31, 2023, respectively

 

 

Common Stock, par value of $0.0001 per share; 200,000,000 shares authorized; 30,166,102 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively

 

30

 

30

Additional paid in capital

 

885

 

Accumulated deficit

 

(21,039)

 

(11,339)

Accumulated other comprehensive loss:

 

  

 

  

Foreign currency translation adjustment

 

(1,609)

 

(1,416)

Unrealized pension actuarial gains, net of tax

 

972

 

157

Total accumulated other comprehensive loss

 

(637)

 

(1,259)

Total stockholders’ deficit

 

(20,761)

 

(12,568)

Total liabilities and stockholders’ deficit

$

99,647

$

102,739

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

XBP Europe Holdings, Inc.

Condensed Consolidated Statements of Operations

For the three and nine months ended September 30, 2024 and 2023

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Three months ended September 30, 

Nine months ended September 30, 

    

2024

    

2023

    

2024

    

2023

Revenue, net

$

35,330

$

37,429

$

106,770

$

116,248

Related party revenue, net

 

70

 

67

 

217

 

163

Cost of revenue (exclusive of depreciation and amortization)

 

23,841

 

28,229

 

78,769

 

85,531

Related party cost of revenue

 

7

 

12

 

35

 

75

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

6,818

 

6,846

 

19,785

 

21,448

Related party expense

 

1,421

 

1,316

 

3,527

 

3,589

Depreciation and amortization

 

804

 

745

 

2,387

 

2,207

Operating profit

 

2,509

 

348

 

2,484

 

3,561

Other expense (income), net

 

  

 

  

 

  

 

  

Interest expense, net

 

1,820

 

1,246

 

4,698

 

3,641

Related party interest expense (income), net

 

23

 

5

 

64

 

(1)

Foreign exchange losses (gains), net

 

668

 

(530)

 

2,016

 

405

Changes in fair value of warrant liability

 

(5)

 

 

(45)

 

Pension income, net

 

(435)

 

(200)

 

(1,278)

 

(589)

Net income (loss) before income taxes

 

438

 

(173)

 

(2,971)

 

105

Income tax expense

 

1,664

 

1,046

 

2,666

 

1,523

Net loss from continuing operations

(1,226)

(1,219)

(5,637)

(1,418)

Net loss from discontinuing operations, net of income taxes

(1,543)

(1,668)

(4,063)

(4,533)

Net loss

$

(2,769)

$

(2,887)

$

(9,700)

$

(5,951)

Loss per share:

 

 

  

 

 

 

 

  

 

 

Basic and diluted - continuing operations

$

(0.04)

$

(0.05)

$

(0.19)

$

(0.06)

Basic and diluted - discontinuing operations

(0.05)

(0.08)

(0.13)

(0.21)

Basic and diluted

$

(0.09)

$

(0.13)

$

(0.32)

$

(0.27)

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

XBP Europe Holdings, Inc.

Condensed Consolidated Statements of Comprehensive Loss

For the three and nine months ended September 30, 2024 and 2023

(in thousands of United States dollars)

(Unaudited)

Three months ended September 30, 

Nine months ended September 30, 

    

2024

    

2023

    

2024

    

2023

Net loss

$

(2,769)

$

(2,887)

$

(9,700)

$

(5,951)

Other comprehensive income (loss), net of tax

 

  

 

  

 

  

 

  

Foreign currency translation adjustments

 

(615)

 

853

 

(193)

 

154

Unrealized pension actuarial gains (losses), net of tax

 

278

 

147

 

815

 

(56)

Total other comprehensive loss, net of tax

$

(3,106)

$

(1,887)

$

(9,078)

$

(5,853)

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

XBP Europe Holdings, Inc.

Condensed Consolidated Statements of Stockholders’ Deficit

For the three and nine months ended September 30, 2024 and 2023

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Accumulated Other

Comprehensive Loss

Unrealized

Foreign

Pension

Currency

Actuarial

Common Stock

Additional

Net Parent

Translation

    

Losses,

Accumulated

Total

    

Shares

    

Amount

    

Paid in Capital

    

Investment

    

Adjustment

    

net of tax

    

Deficit

    

Deficit

Balances at December 31, 2022

 

$

$

$

(5,845)

$

(17,789)

$

(3,298)

$

$

(26,932)

Net loss January 1, 2023 to March 31, 2023

 

 

 

 

(2,506)

 

 

 

 

(2,506)

Foreign currency translation adjustment

 

 

 

 

(194)

 

 

 

(194)

Net unrealized pension actuarial losses, net of tax

 

 

 

 

 

(90)

 

 

(90)

Balances at March 31, 2023

$

$

$

(8,351)

$

(17,983)

$

(3,388)

$

$

(29,722)

Net loss April 1, 2023 to June 30, 2023

(558)

(558)

Classification adjustment

(18,987)

18,987

Foreign currency translation adjustment

 

 

 

 

(505)

 

 

(505)

Net unrealized pension actuarial losses, net of tax

 

 

 

 

 

(113)

 

(113)

Balances at June 30, 2023

$

$

$

(27,896)

$

499

$

(3,501)

$

$

(30,898)

Net loss July 1, 2023 to September 30, 2023

(2,887)

(2,887)

Foreign currency translation adjustment

 

 

 

 

 

853

 

 

 

853

Net unrealized pension actuarial losses, net of tax

 

 

 

 

 

 

147

 

 

147

Balances at September 30, 2023

 

$

$

$

(30,783)

$

1,352

$

(3,354)

$

$

(32,785)

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

The accompanying notes are an integral part of these condensed consolidated financial statements

XBP Europe Holdings, Inc.

Condensed Consolidated Statements of Stockholders’ Deficit

For the three and nine months ended September 30, 2024 and 2023

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

Accumulated Other

Comprehensive Loss

Unrealized

Foreign

Pension

Currency

Actuarial

Common Stock

Additional

Net Parent

Translation

    

Gains,

Accumulated

Total

Shares

    

Amount

    

Paid in Capital

    

Investment

    

Adjustment

    

net of tax

    

Deficit

    

Deficit

Balances at December 31, 2023

30,166,102

$

30

$

$

$

(1,416)

$

157

$

(11,339)

$

(12,568)

Net loss January 1, 2024 to March 31, 2024

 

 

 

 

 

 

 

(2,208)

 

(2,208)

Foreign currency translation adjustment

 

 

 

 

 

278

 

 

 

278

Net unrealized pension actuarial gains, net of tax

 

 

 

 

 

 

290

 

 

290

Balances at March 31, 2024

 

30,166,102

$

30

$

$

$

(1,138)

$

447

$

(13,547)

$

(14,208)

Net loss April 1, 2024 to June 30, 2024

(4,723)

(4,723)

Equity-based compensation

160

160

Foreign currency translation adjustment

144

144

Net unrealized pension actuarial gains, net of tax

 

 

 

 

 

247

 

 

247

Balances at June 30, 2024

30,166,102

$

30

$

160

$

$

(994)

$

694

$

(18,270)

$

(18,380)

Net loss July 1, 2024 to September 30, 2024

(2,769)

(2,769)

Equity-based compensation

725

725

Foreign currency translation adjustment

(615)

(615)

Net unrealized pension actuarial gains, net of tax

 

 

 

 

 

 

278

 

 

278

Balances at September 30, 2024

 

30,166,102

$

30

$

885

$

$

(1,609)

$

972

$

(21,039)

$

(20,761)

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

XBP Europe Holdings, Inc.

Condensed Consolidated Statements of Cash Flows

For the nine months ended September 30, 2024 and 2023

(in thousands of United States dollars)

(Unaudited)

Nine months ended September 30, 

    

2024

    

2023

Cash flows from operating activities

Net loss

$

(9,700)

$

(5,951)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

  

Depreciation

 

2,265

 

2,662

Amortization of intangible assets

 

554

 

289

Impairment of goodwill

87

Credit loss expense

 

249

 

271

Changes in fair value of warrant liability

(45)

Stock-based compensation expense

885

Unrealized foreign currency losses

 

1,976

 

215

Change in deferred income taxes

 

(761)

 

(357)

Change in operating assets and liabilities

 

 

  

Accounts receivable

 

5,741

 

2,874

Inventories

 

163

 

326

Prepaid expense and other assets

 

(855)

 

1,125

Accounts payable

 

(2,555)

 

(2,599)

Related parties payable

 

(8,350)

 

(2,246)

Accrued expenses and other liabilities

 

(1,428)

 

4,758

Deferred revenue

 

280

 

790

Customer deposits

 

340

 

(414)

Net cash provided by (used in) operating activities

 

(11,154)

 

1,743

Cash flows from investing activities

 

 

  

Purchase of property, plant and equipment

 

(1,124)

 

(2,254)

Additions to internally developed software

(317)

Net cash used in investing activities

 

(1,441)

 

(2,254)

Cash flows from financing activities

 

 

  

Borrowings under secured borrowing facility

 

 

87,769

Principal repayment on borrowings under secured borrowing facility

 

(79)

 

(90,357)

Borrowings under 2024 Term Loan A Facility

3,830

Borrowings under 2024 Term Loan B Facility

11,413

Borrowings under 2024 Revolving Credit Facility

15,425

Cash paid for debt issuance costs

(734)

Principal payments on 2024 Term Loan A Facility

(192)

Principal payments on 2024 Term Loan B Facility

(571)

Principal payments on long-term obligations

(15,256)

(690)

Proceeds from Secured Credit Facility

 

679

 

Principal payments on finance leases

 

(282)

 

(660)

Net cash provided by (used in) financing activities

 

14,233

 

(3,938)

Effect of exchange rates on cash and cash equivalents

 

(583)

 

(205)

Net increase (decrease) in cash and cash equivalents

 

1,055

 

(4,654)

Cash and equivalents, beginning of period, including cash from discontinued operations

 

6,905

 

7,473

Cash and equivalents, end of period, including cash from discontinued operations

$

7,960

$

2,819

Supplemental cash flow data:

 

  

 

  

Income tax payments, net of refunds received

 

424

 

1,112

Interest paid

 

1,869

 

1,309

The accompanying notes are an integral part of these condensed consolidated financial statements.

8

XBP Europe Holdings, Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands of United States dollars except share and per share amounts)

(Unaudited)

1.General

XBP Europe Holdings, Inc. (the “Company” or “XBP Europe”) is a pan-European integrator of bills, payments and related solutions and services seeking to enable digital transformation of businesses. The Company’s name — “XBP” — stands for “exchange for bills and payments” and reflects the Company’s strategy to facilitate connections between buyers and suppliers to optimize clients’ bills and payments and related digitization processes. XBP believes its business ultimately advances digital transformation, improves market-wide liquidity, and encourages sustainable business practices.

The Company provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients’ strategic journeys and streamlining their complex, disconnected payment processes. The Company serves over 2,000 clients across Europe, the Middle East and Africa (“EMEA”). The Company’s client relationships span multiple industries, including banking, healthcare, insurance, and the public sector. The Company is able to deploy its solutions to clients in any EMEA market due to its cloud-based structure. Its physical footprint spans 15 countries with 32 locations.

These condensed consolidated financial statements should be read in conjunction with the below notes and the notes to the consolidated financial statements as of and for the year ended December 31, 2023 included in the XBP Europe annual report on Form 10-K for such period (the “2023 Form 10-K”), filed with the Securities and Exchange Commission (“SEC”) on April 1, 2024 and available at the SEC’s website at http://www.sec.gov.

The accompanying condensed consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America (“GAAP”) and in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”), as they apply to interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. These accounting principles require the Company to use estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. Actual results may differ from the Company’s estimates.

The condensed consolidated financial statements are unaudited, but include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim period. The interim financial results are not necessarily indicative of results that may be expected for any other interim period or the fiscal year.

Merger/Business Combination with CF Acquisition Corp. VIII

The Company was a special purpose acquisition company called CF Acquisition Corp. VIII (“CF VIII”) prior to the closing of a business combination (the “Business Combination”) on November 29, 2023. Pursuant to that certain Agreement and Plan of Merger, dated October 9, 2022 (the “Merger Agreement”) whereby XBP Europe, Inc., a Delaware corporation, and an indirect subsidiary of Exela Technologies, Inc., a Delaware corporation (“ETI”), became a wholly owned subsidiary of CFV III. In connection with the consummation of the Business Combination, the Company changed its name from CF VIII to “XBP Europe Holdings, Inc.” The Business Combination was accounted for as a reverse capitalization in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). Under this method of accounting, CF VIII was treated as the “acquired” company for financial reporting purposes with XBP Europe surviving as a direct wholly-owned subsidiary of CF VIII.

9

Divesture

During the third quarter of fiscal year 2024, the Company determined that its certain on-demand printing operations met the criteria to be classified as a discontinued operation, and, as a result, disposable group’s historical financial results are reflected in the Company’s condensed consolidated financial statements as discontinued operations, and assets and liabilities were retrospectively reclassified as assets and liabilities held for sale. See Note 3 - Discontinued Operations of the notes to condensed consolidated financial statements.

2.Reverse Recapitalization

As discussed in Note 1, on November 29, 2023, the Company consummated a business combination pursuant to the Merger Agreement. The Business Combination was accounted for as a Reverse Recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, XBP Europe was deemed the accounting acquirer (and legal acquiree) and CF VIII was treated as the accounting acquiree (and legal acquirer). Under this method of accounting, the reverse recapitalization was treated as the equivalent of XBP Europe issuing stock for the net assets of CF VIII, accompanied by a recapitalization. XBP Europe has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:

XBP Europe pre-combination stockholder has the majority of the voting power in the post-Business Combination company;
XBP Europes stockholder has the ability to appoint a majority of the Companys board of directors (the Board);
XBP Europes management team is the management team of the post-Business Combination company;
XBP Europes prior operations is comprised of the ongoing operations of the post-Business Combination company;
XBP Europe is the larger entity based on historical revenues and business operations; and
The post-Business Combination company has assumed XBP Europes operating name.

The net assets of CF VIII are stated at historical cost, with no incremental goodwill or other intangible assets recorded for the effects of the Business Combination. The consolidated assets, liabilities, and results of operations prior to the Business Combination are those of XBP Europe. The shares and corresponding capital amounts and earnings per share available for common stockholders, prior to the Business Combination, have been retroactively restated.

Upon closing of the Business Combination, the Company received net proceeds of $5.2 million from the Business Combination.

Transaction costs consist of directors and officers liability insurance cost, legal and professional fees, and other fees relating to the consummation of the Business Combination. The Company incurred $3.3 million in transaction costs relating to the Merger for the year ended December 31, 2023, $0.3 million of which was recorded to additional paid-in capital and the remaining $3.0 million was expensed.

Immediately after giving effect to the Business Combination, there were 30,166,102 shares of common stock outstanding, 6,249,980 Public Warrants outstanding and 385,000 Private Warrants outstanding. See Note 16 – Warrants and Note 17 – Stockholders’ Deficit for more details.

10

3.Discontinued Operations

The Company classifies assets as held-for-sale (“disposal group”) in the period when all of the relevant criteria to be classified as held for sale are met. These criteria include management’s commitment to sell the disposal group in its present condition and the sale being deemed probable of being completed within one year. Assets held for sale are reported at the lower of their carrying value or fair value less cost to sell. The fair values of disposal groups are estimated using accepted valuation techniques, including indicative listing prices. The Company considers historical experience, guidance received from third parties, and all information available at the time the estimates are made to derive fair value. Any loss resulting from the measurement is recognized in the period when the held for sale criteria are met. The Company assesses the fair value of a disposal group, less any costs to sell, each reporting period it remains classified as held for sale and reports any subsequent changes as an adjustment to the carrying value of the disposal group, as long as the new carrying value does not exceed the initial carrying value of the disposal group. Assets held-for-sale are not amortized or depreciated.

As of September 30, 2024, certain on-demand printing operations of the Company met the criteria for classification as held for sale and accordingly, was measured at the lower of their carrying value or its fair value less costs to sell. The Company recorded an impairment charge of $0.1 million relating to the disposal group in impairment of goodwill in the condensed consolidated statement of operations of the disposable group for the three and nine months ended September 30, 2024. The Company determined that the held for sale disposal group has met the criteria to be disclosed as discontinued operations as it represents a significant strategic shift that will have a major effect on the Company’s operations and financial results.

The results of the disposable group are presented as discontinued operations in the condensed consolidated statements of operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Impairment loss was recorded during the three and nine months ended September 30, 2024, in impairment of assets in the condensed consolidated statements of operations. Further, the Company has reclassified the assets and liabilities of the disposable group as assets and liabilities held for sale in the condensed consolidated statements of balance sheets for all periods presented. The condensed consolidated statements of cash flows are presented on a consolidated basis for both continuing operations and discontinued operations. Unless otherwise noted, reference within the notes to condensed consolidated financial statements relates to continuing operations.

The financial results of the disposable group are presented as loss from discontinued operations, net of income taxes on the Company’s condensed consolidated statements of operations. The following table presents the major components of financial results of the Company’s disposable group for the periods presented:

11

Three months ended September 30, 

Nine months ended September 30, 

(dollars in thousands)

    

2024

    

2023

    

2024

    

2023

Revenue, net

$

1,898

$

2,749

$

6,773

$

9,002

Cost of revenue (exclusive of depreciation and amortization)

 

2,069

 

3,139

 

7,009

 

9,795

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

1,015

 

895

 

2,899

 

2,888

Related party expense

 

58

 

13

 

129

 

38

Depreciation and amortization

 

135

 

350

 

432

 

744

Impairment of goodwill (1)

 

87

 

 

87

 

Operating loss

 

(1,466)

 

(1,648)

 

(3,783)

 

(4,463)

Other expense, net

 

  

 

  

 

  

 

  

Interest expense, net

 

3

 

19

 

18

 

64

Foreign exchange losses, net

 

2

 

1

 

190

 

6

Net loss from discontinuing operations before income taxes

 

(1,471)

 

(1,668)

 

(3,991)

 

(4,533)

Income tax expense

 

72

 

 

72

 

Net loss from discontinuing operations, net of income taxes

$

(1,543)

$

(1,668)

$

(4,063)

$

(4,533)

(1)During the third quarter of 2024, the Company recorded $0.1 million impairment in goodwill for the three and nine months ended September 30, 2024, due to held for sale classification as discussed above.

As of September 30, 2024, the assets and liabilities of the disposable group are classified as current in the Company’s condensed consolidated balance sheets, as it is probable that the sale will occur within one year. The following table represents the aggregated carrying amounts of classes of assets and liabilities that are classified as discontinued operations on the condensed consolidated balance sheets for the periods presented:

September 30, 

(dollars in thousands)

    

2024

ASSETS

 

  

Current assets

 

  

Cash and cash equivalents

$

190

Accounts receivable, net of allowance for credit losses of $86

 

481

Inventories, net

 

582

Prepaid expenses and other current assets

 

697

Property, plant and equipment, net of accumulated depreciation of $3,593

855

Operating lease right-of-use assets, net

 

1,392

Total current assets held for sale

$

4,197

LIABILITIES

 

  

Current liabilities

 

  

Accounts payable

$

802

Accrued liabilities

 

1,463

Accrued compensation and benefits

 

356

Customer deposits

 

162

Current portion of finance lease liabilities

 

353

Current portion of operating lease liabilities

 

1,393

Total current liabilities held for sale

$

4,529

12

December 31, 

(dollars in thousands)

    

2023

ASSETS

 

  

Current assets

 

  

Cash and cash equivalents

$

368

Accounts receivable, net of allowance for credit losses of $89

 

557

Inventories, net

 

695

Prepaid expenses and other current assets

 

877

Total current assets held for sale

$

2,497

Property, plant and equipment, net of accumulated depreciation of $3,114

$

1,188

Operating lease right-of-use assets, net

 

1,659

Goodwill

 

87

Deferred income tax assets

50

Other noncurrent assets

34

Total noncurrent assets held for sale

$

3,018

LIABILITIES

 

  

Current liabilities

 

  

Accounts payable

$

1,133

Accrued liabilities

 

892

Accrued compensation and benefits

 

315

Customer deposits

 

213

Current portion of finance lease liabilities

 

547

Current portion of operating lease liabilities

 

379

Total current liabilities held for sale

$

3,479

Operating lease liabilities, net of current portion

 

1,280

Total noncurrent liabilities held for sale

$

1,280

The following table presents significant non-cash items and capital expenditures of discontinued operations for the periods presented:

Nine months ended September 30, 

(dollars in thousands)

    

2024

    

2023

Depreciation

 

$

432

$

744

Impairment of goodwill

87

Credit loss expense (income)

7

(9)

Unrealized foreign currency losses

 

184

Purchase of property, plant and equipment

 

$

(94)

$

(174)

4.New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Effective January 1, 2024, the Company adopted ASU No. 2023-01, Leases (Topic 842): Common Control Arrangements. The FASB-issued guidance clarifies the accounting for leasehold improvements associated with common control leases by requiring that leasehold improvements associated with common control leases be amortized by the lessee over the useful life of the leasehold improvements to the common control group (regardless of the lease term), as long as the lessee controls the use of the underlying asset through a lease. Additionally, leasehold improvements

13

associated with common control leases should be accounted for as a transfer between entities under common control through an adjustment to equity, if, and when, the lessee no longer controls the use of the underlying asset. The adoption had no impact on the Company’s consolidated results of operations, cash flows, financial position or disclosures.

Recently Issued Accounting Pronouncements

In October 2023, the FASB issued ASU No. 2023-06, Disclosure Improvements-Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, which modifies the disclosure and presentation requirements of a variety of US GAAP codification topics by aligning them with the SEC Regulation S-X or S-K, which are rules about the form and content of financial reports. The provisions of this ASU are contingent upon when the SEC removes the related disclosure provisions from Regulation S-X and S-K. This guidance is effective for the Company no later than June 30, 2027 and is not expected to have a material impact on the Company’s consolidated financial statements.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires retrospective disclosure of significant segment expenses and other segment items on an annual and interim basis. Additionally, it requires disclosure of the title and position of the Chief Operating Decision Maker (“CODM”). This ASU is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that adopting this standard will have on its consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires an annual tabular effective tax rate reconciliation disclosure including information for specified categories and jurisdiction levels, as well as, disclosure of income taxes paid, net of refunds received, disaggregated by federal, state/local, and significant foreign jurisdiction. This ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact that adopting this standard will have on its consolidated financial statements.

5.Summary of Significant Accounting Policies

The information presented below supplements the Significant Accounting Policies information presented in the 2023 Form 10-K.

Stock-Based Compensation

The Company accounts for all equity-classified awards under stock-based compensation plans at their “fair value.” This fair value is measured at the fair value of the awards at the grant date and recognized as compensation expense on a straight-line basis over the vesting period. The fair value of the awards on the grant date is determined using the stock price on the respective grant date in the case of restricted stock units and using an option pricing model in the case of stock options. The Company accounts for forfeitures as they occur. The expense resulting from share-based payments is recorded in selling, general and administrative expense in the condensed consolidated statements of operations.

Revenue Recognition

The Company accounts for revenue in accordance with ASC 606, Revenue from Contracts with Customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC 606. Revenue is measured as the amount of consideration that is expected to receive in exchange for transferring goods or providing services. The contract transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. All of the Company’s material sources of revenue are derived from contracts with customers, primarily relating to the provision of business and transaction processing services and sales of recurring software licenses and professional services within each of the Company’s segments. The Company does not have any significant extended payment terms, as payment for invoices issued is received shortly after goods are delivered or services are provided.

14

Nature of Services

The primary performance obligations are to stand ready to provide various forms of business processing services, consisting of a series of distinct services that are substantially the same and have the same pattern of transfer over time, and accordingly are combined into a single performance obligation. The Company’s promise to its customers is typically to perform an unknown or unspecified quantity of tasks and the consideration received is contingent upon the customers’ use (i.e., number of transactions processed, requests fulfilled, etc.); as such, the total transaction price is variable. The variable fees are allocated to the single performance obligation charged to the distinct service period in which the Company performs the service.

Revenue from the sale of recurring software licenses is recognized ratably over the contractual term, unless perpetual licenses are granted or a noncancelable license is granted for a nonrefundable fee, which are recognized at a point in time. Professional services revenue consists of implementation services for new customers, or implementations of new products for existing customers. Professional services are typically sold on a time-and-materials basis and billed monthly based on actual hours incurred.

Revenue from the sale of hardware solutions is recognized on a point in time basis and related maintenance are recognized ratably over the contractual term.

Disaggregation of Revenues

The following tables disaggregate revenue from contracts by geographic region for the three and nine months ended September 30, 2024 and 2023:

Three months ended

Nine months ended

September 30, 

September 30, 

(dollars in thousands)

    

2024

    

2023

    

2024

    

2023

France

$

11,694

$

12,659

$

38,694

$

44,564

Germany

 

9,158

 

11,124

 

27,824

 

23,890

United Kingdom

 

9,601

 

7,482

 

24,339

 

26,903

Sweden

 

2,947

 

3,409

 

10,031

 

13,392

Other

 

1,930

 

2,755

 

5,882

 

7,499

Total Revenue, net

$

35,330

$

37,429

$

106,770

$

116,248

Contract Balances

The following table presents contract assets, contract liabilities and contract costs recognized at September 30, 2024 and December 31, 2023:

September 30, 

December 31, 

(dollars in thousands)

    

2024

    

2023

Accounts receivable, net

$

24,576

$

30,238

Deferred revenues

 

6,500

 

6,004

Customer deposits

 

723

 

323

Costs to obtain and fulfill a contract

$

88

$

350

Accounts receivable, net includes $10.6 million and $10.8 million as of September 30, 2024 and December 31, 2023, respectively, representing amounts not billed to customers. Unbilled receivables are accrued and represent work performed in accordance with the terms of contracts with customers.

Deferred revenues relate to payments received in advance of performance under a contract. A significant portion of this balance relates to maintenance contracts or other service contracts where the Company received payments for upfront conversions or implementation activities which do not transfer a service to the customer but rather are used in fulfilling the related performance obligations that transfer over time. The advance consideration received from customers

15

is deferred over the contract term. The Company recognized revenue of $3.0 million and $6.4 million during the three and nine months ended September 30, 2024, respectively, that had been deferred as of December 31, 2023. The Company recognized revenue of $6.3 million during the year ended December 31, 2023 that had been deferred as of January 1, 2023.

Costs incurred to obtain and fulfill contracts are deferred and presented as part of intangible assets, net and expensed on a straight-line basis over the estimated benefit period. These costs represent incremental external costs or certain specific internal costs that are directly related to the contract acquisition or fulfillment and can be separated into two principal categories: contract commissions and fulfillment costs. Applying the practical expedient in ASC 340-40-25-4, the incremental costs of obtaining contracts are recognized as an expense when incurred if the amortization period would have been one year or less. These costs are included in selling, general and administrative expenses. The effect of applying this practical expedient was not material.

Customer deposits consist primarily of amounts received from customers in advance for postage. These advanced postage deposits are used to cover the costs associated with postage, with the corresponding postage revenue being recognized as services are performed.

Performance Obligations

At the inception of each contract, the Company assesses the goods and services promised in the Company’s contracts and identifies each distinct performance obligation. The majority of the Company’s contracts have a single performance obligation, as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts. For the majority of the Company’s business and transaction processing service contracts, revenues are recognized as services are provided based on an appropriate input or output method, typically based on the related labor or transactional volumes.

Certain of the Company’s contracts have multiple performance obligations, including contracts that combine software implementation services with post-implementation customer support. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract. The primary method used to estimate standalone selling price is the expected cost plus a margin approach, under which the Company estimates the expected costs of satisfying a performance obligation and adds an appropriate margin for that distinct good or service. The adjusted market approach is also used whereby the Company estimates the price that customers in the market would be willing to pay. In assessing whether to allocate variable consideration to a specific part of the contract, the Company considers the nature of the variable payment and whether it relates specifically to its efforts to satisfy a specific part of the contract. Certain of the Company’s software implementation performance obligations are satisfied at a point in time, typically when customer acceptance is obtained.

When evaluating the transaction price, the Company analyzes, on a contract-by-contract basis, all applicable variable considerations. The nature of the Company’s contracts gives rise to variable consideration, including volume discounts, contract penalties, and other similar items that generally decrease the transaction price. These amounts are estimated based on the expected amount to be provided to customers and reduce revenues recognized. The Company does not anticipate significant changes to its estimates of variable consideration.

Reimbursements from customers, such as postage costs, are included in revenue, while the related costs are included in cost of revenue.

16

Transaction Price Allocated to the Remaining Performance Obligations

In accordance with optional exemptions available under ASC 606, the Company did not disclose the value of unsatisfied performance obligations for (a) contracts with an original expected length of one year or less, and (b) contracts for which variable consideration relates entirely to an unsatisfied performance obligation, which comprise the majority of the Company’s contracts. The Company has certain non-cancellable contracts where a fixed monthly fee is received in exchange for a series of distinct services that are substantially the same and have the same pattern of transfer over time, with the corresponding remaining performance obligations as of September 30, 2024 in each of the future periods below:

(dollars in thousands)

    

Remainder of 2024

$

4,918

2025

 

1,379

2026

 

141

2027

 

62

Total

$

6,500

Net Loss per Share

Earnings per share (“EPS”) is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock, using the more dilutive of the two-class method and if-converted method in the period of earnings. The two-class method is an earnings allocation method that determines earnings per share (when there are earnings) for common stock and participating securities. The if-converted method assumes all convertible securities are converted into common stock. Diluted EPS excludes all dilutive potential shares of common stock if their effect is anti-dilutive.

As the Company experienced net losses for the periods presented, the Company did not include the effect of 6,634,980 shares of common stock issuable upon exercise of 6,634,980 warrants sold in the IPO and Private Placement and issued in connection with completion of the Business Combination, or the effect of the aggregate number of shares issuable pursuant to outstanding restricted stock units and options (3,420,329 as of September 30, 2024) in the calculation of diluted loss per share for the three and nine months ended September 30, 2024 and 2023, because their effects were anti-dilutive.

The components of basic and diluted EPS are as follows:

    

Three months ended

Nine months ended

September 30, 

September 30, 

(dollars in thousands, except share and per share amounts)

    

2024

    

2023

    

2024

    

2023

Net loss from continuing operations attributable to common stockholders (A)

$

(1,226)

$

(1,219)

$

(5,637)

$

(1,418)

Net loss from discontinuing operations attributable to common stockholders (B)

(1,543)

(1,668)

(4,063)

(4,533)

Net loss attributable to common stockholders (C)

$

(2,769)

$

(2,887)

$

(9,700)

$

(5,951)

Weighted average common shares outstanding – basic and diluted (D)

 

30,166,102

 

21,802,689

 

30,166,102

 

21,802,689

Income (Loss) Per Share:

 

 

 

 

 

 

 

 

Basic and diluted - continuing operations (A/D)

$

(0.04)

$

(0.05)

$

(0.19)

$

(0.06)

Basic and diluted - discontinuing operations (B/D)

(0.05)

(0.08)

(0.13)

(0.21)

Basic and diluted (C/D)

$

(0.09)

$

(0.13)

$

(0.32)

$

(0.27)

17

6.Inventories

Inventories, net consist of the following:

September 30, 

December 31, 

(dollars in thousands)

    

2024

    

2023

Finished goods

$

5,946

$

5,892

Allowance for obsolescence

 

(1,890)

 

(1,847)

Total inventories, net

$

4,056

$

4,045

Finished goods inventory includes $1.9 million and $1.8 million of allowance for obsolescence as of September 30, 2024 and December 31, 2023, respectively. The Company allowance for obsolescence is based on a policy developed by historical experience and management judgment.

7.Accounts Receivable

Accounts receivable, net consist of the following:

September 30, 

December 31, 

(dollars in thousands)

    

2024

    

2023

Billed receivables

$

15,446

$

20,584

Unbilled receivables

 

10,565

 

10,837

Less: Allowance for credit losses

 

(1,435)

 

(1,183)

Total accounts receivable, net

$

24,576

$

30,238

Unbilled receivables represent balances recognized as revenue that have not been billed to the customer. The Company allowance for doubtful accounts is based on a policy developed by historical experience and management judgment. Adjustments to the allowance for credit losses may occur based on market conditions or specific client circumstances.

The following table describes the changes in the allowance for expected credit losses for the nine months ended September 30, 2024 (all related to accounts receivables):

(dollars in thousands)

    

    

Balance at January 1, 2024 of the allowance for expected credit losses

$

1,183

Change in the provision for expected credit losses for the period

 

252

Balance at September 30, 2024 of the allowance for expected credit losses

$

1,435

18

8.Property, Plant and Equipment, Net

Property, plant, and equipment, which include assets recorded under finance leases, are stated at cost less accumulated depreciation, and amortization, and consist of the following:

    

Expected Useful Lives 

    

September 30, 

December 31, 

(dollars in thousands)

    

(in Years)

    

2024

    

2023

Buildings and improvements

 

740

$

9,397

$

9,115

Leasehold improvements

 

Shorter of life of improvement or lease term

 

649

 

686

Machinery and equipment

 

515

 

7,438

 

7,033

Computer equipment and software

 

38

 

27,394

 

26,324

Furniture and Fixtures

 

515

 

8,327

 

7,765

Finance lease right-of use assets

 

Shorter of life of the asset or lease term

 

1,786

 

1,764

 

54,991

 

52,687

Less: Accumulated depreciation and amortization

 

(42,707)

 

(39,876)

Total property, plant and equipment, net

$

12,284

$

12,811

Depreciation expense related to property, plant and equipment was $0.6 million and $0.6 million for the three months ended September 30, 2024 and 2023, respectively, and $1.8 million and $2.0 million for the nine months ended September 30, 2024 and 2023, respectively.

9.Intangible Assets and Goodwill

Intangible Assets

Intangible assets are stated at cost or acquisition-date fair value less accumulated amortization and consists of the following:

Weighted

Average

September 30, 2024

Remaining

Gross

Useful Life

Carrying

Accumulated

Intangible Asset,

(dollars in thousands)

    

(in Years)

    

 Amount (a)

    

Amortization

    

net

Customer relationships

 

2.3

$

3,180

$

(2,311)

$

869

Internally developed software

5.0

329

(12)

317

Outsource contract costs

 

0.3

 

773

 

(685)

 

88

Total intangibles, net

$

4,282

$

(3,008)

$

1,274

Weighted

Average

December 31, 2023

Remaining

Gross

Useful Life

Carrying

Accumulated

Intangible Asset,

(dollars in thousands)

    

(in Years)

    

 Amount (a)

    

Amortization

    

net

Customer relationships

 

3.0

$

3,145

$

(1,997)

$

1,148

Outsource contract costs

 

1.0

 

768

 

(418)

 

350

Total intangibles, net

$

3,913

$

(2,415)

$

1,498

(a)Amounts include intangibles acquired in business combinations and asset acquisitions

Aggregate amortization expense related to intangibles was $0.2 million and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and $0.6 million and $0.3 million for the nine months ended September 30, 2024 and 2023, respectively.

19

Estimated intangibles amortization expense for the next five years consists of the following:

Estimated

Amortization

(dollars in thousands)

    

Expenses

Remainder of 2024

$

201

2025

 

452

2026

446

2027

 

63

2028 and thereafter

112

Total

$

1,274

Goodwill

The Company’s operating segments are significant strategic business units that align its products and services with how it manages its business, approach the markets and interacts with customers. The Company is organized into two segments: Bills and Payments and Technology (See Note 20 – Segment Information).

Goodwill by reporting segment consists of the following:

Balances at

Currency

Balances at

January 1,

Translation

September 30, 

(dollars in thousands)

    

2024

    

Additions

    

Disposals

    

Impairments

    

Adjustments

    

2024

Bills and Payments

$

9,971

$

$

$

$

176

$

10,147

Technology

 

12,852

 

 

 

 

282

 

13,134

Total

$

22,823

$

$

$

$

458

$

23,281

Balances at

Currency

Balances at

January 1,

Translation

December 31, 

(dollars in thousands)

    

2023

    

Additions

    

Disposals

    

Impairments

    

Adjustments

    

2023

Bills and Payments

$

9,602

$

$

$

$

369

$

9,971

Technology

 

12,373

 

 

 

 

479

 

12,852

Total

$

21,975

$

$

$

$

848

$

22,823

10.Debt

Secured Borrowing Facility

On August 25, 2020, certain entities entered into an agreement wherein amounts due from clients were pledged to a third party, in exchange for a borrowing facility in amounts up to a total of €31.0 million (the “Secured Borrowing Facility”). The proceeds from the Secured Borrowing Facility were determined by the amounts invoiced to the Company’s clients. The amounts due from clients were recorded in accounts receivable and the amount due to the third party as a liability, presented under current portion of long-term debt on the condensed consolidated balance sheets. The cost of the Secured Borrowing Facility was 0.10% of newly assigned receivables with minimum of €0.1 million in annual fees and the Secured Borrowing Facility bore interest at Euribor rate plus 0.70% on the unpaid principal amount. During the three months ended September 30, 2024 and 2023, the Company incurred interest expense of $0 and $0.1 million, respectively, and $0 and $0.4 million for the nine months ended September 30, 2024 and 2023, respectively, related to the Secured Borrowing Facility. As of September 30, 2024 and December 31, 2023, the outstanding balances payable under the Secured Borrowing Facility were $0 and $0.1 million, respectively.

On September 15, 2023, the relevant entities entered into an amendment to the Secured Borrowing Facility (the “Amended Factoring Agreement”) to convert the existing arrangement into a non-recourse factoring program wherein an unrelated third party (the “Factor”) shall provide financing to certain subsidiaries of the Company by purchase of certain approved and partially approved accounts receivables (as defined in the Amended Factoring Agreement) up to a maximum amount of €15.0 million while assuming the risk of non-payment on the purchased accounts receivables up to

20

the level of approval. The relevant entities shall have no continuing involvement in the transferred accounts receivable, other than collection and administrative responsibilities and, once sold, the accounts receivable shall no longer be available to satisfy creditors of the relevant entities.

The Company accounted for the transactions under the Amended Factoring Agreement as a sale under ASC 860, Transfers and Servicing, and treats it as an off-balance sheet arrangement. Net funds received from the transfers reflect the face value of the account less a fee, which is recorded as an increase to cash and a reduction to accounts receivable outstanding in the condensed consolidated balance sheets. The Company reports the cash flows attributable to the sale of account receivables to the Factor and the cash receipts from collections made on behalf of and paid to the Factor under the Amended Factoring Agreement, on a net basis as trade accounts receivables in cash flows from operating activities in the Company’s condensed consolidated statements of cash flows.

As of September 30, 2024, the Company’s outstanding factored accounts receivable amounted to $9.2 million pursuant to the Amended Factoring Agreement, representing the face value of the invoices. The Company recognizes factoring costs upon disbursement of funds. The Company incurred a loss on sale of accounts receivables including expenses pursuant to the Amended Factoring Agreement totaling approximately $0.3 million and $0.7 million for the three and nine months ended September 30, 2024, respectively, which is presented in selling, general and administrative expenses (exclusive of depreciation and amortization) on the condensed consolidated statements of operations.

2019 Credit Agreement

In October 2019, a wholly-owned UK subsidiary of XBP Europe (the “UK Subsidiary”) entered into a secured credit agreement (the “2019 Credit Agreement”) with HSBC UK Bank plc (“HSBC”) for a £9.0 million Secured Credit Facility (the “Secured Credit Facility”) consisting of (i) a secured Term Loan A facility in an aggregate principal amount of £2.0 million (the “Term Loan A Facility”), (ii) a secured Term Loan B facility in an aggregate principal amount of £2.0 million (the “Term Loan B Facility”), and (iii) a secured revolving credit facility in an aggregate principal amount of £5.0 million (the “Revolving Credit Facility”). On December 21, 2022, the UK Subsidiary amended its 2019 Credit Agreement, allowing the UK Subsidiary to affirm to extend the maturity of Term Loan A Facility and Term Loan B Facility to October 31, 2024 subject to compliance with financial covenants. On February 9, 2023, the UK Subsidiary amended its 2019 Credit Agreement, allowing the UK Subsidiary to extend the maturity of the Revolving Credit Facility to October 31, 2024 subject to compliance with financial covenants. The maturity of the Revolving Credit Facility has since been extended on various dates. On May 10, 2024, the maturity was further extended to August 31, 2025. During the nine months ended September 30, 2024, the Company has repaid outstanding amount of $1.7 million, $0.2 million, and $6.3 million under the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility, respectively and accordingly wrote off the unamortized balance of less than $0.1 million of debt issuance cost related to the 2019 Credit Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2019 Credit Agreement. As of December 31, 2023, the outstanding balance of the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility was $1.9 million, $0.4 million, and $6.4 million, respectively.

The 2019 Credit Agreement contains financial covenants including, but not limited to (a) a Combined Cashflow Coverage Ratio, which measures the ratio of (i) Combined Cashflow and (ii) Debt Service defined as finance charges in addition to mandatory repayments in respect to the 2019 Credit Agreement, (b) Combined Interest Coverage Ratio, which measures the ratio of (i) Combined EBITDA to (ii) Combined Finance Charges, (c) a Combined Total Net Leverage Ratio, which measures the ratio of (i) Combined Net Indebtedness in respect to the last day of the most recent period to (ii) EBITDA, (d) Guaranteed Intragroup Balances, (e) the Loan to Market Value defined as the Facility A Loan outstanding to the market value of the property in each case, as defined in the 2019 Credit Agreement. The term “Combined” refers to the UK Subsidiary and its wholly-owned subsidiaries.

The 2019 Credit Agreement and indenture governing the Secured Credit Facility contains limitations on the ability of the UK subsidiary to effect mergers and change of control events as well as certain other limitations, including limitations on: (i) the declaration and payment of dividends or other restricted payments (ii) substantial changes of the

21

general nature of the business, (iii) acquisition of a company, (iv) enter a joint venture, (v) or effect a dormant subsidiary to commence trading or cease to satisfy the criteria of a dormant subsidiary.

The UK Subsidiary’s obligations under the 2019 Credit Agreement are jointly and severally guaranteed by certain of its existing and future direct and indirectly wholly owned subsidiaries. The 2019 Credit Agreement and the 2022 Committed Facility Agreement (defined below) contain cross default provisions which relate to the UK Subsidiary and its subsidiaries, but not any other entities within the consolidated group.

At inception, borrowings under the Secured Credit Facility bore interest at a rate per annum equal to the LIBOR plus the applicable margin of 2%, 2.5%, and 3% per annum for the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility respectively. Effective October 29, 2021, borrowings under the Revolving Credit Facility bore interest at a rate per annum equal to the Sterling Overnight Index Average (“SONIA”) plus the applicable margin of 3%. Effective December 31, 2021, borrowings under the Term Loan A Facility and the Term Loan B Facility bore interest at a rate per annum equal to the SONIA plus the applicable margin of 2% and 2.5%, respectively.

In June 2020, the UK Subsidiary entered into an amendment to the 2019 Credit Agreement, to provide an additional aggregate principal amount of £4.0 million under a credit agreement (the “Revolving Working Capital Loan Facility” or “2020 Credit Agreement”) together with Revolving Credit Facility (the “Revolving Credit Facilities”). At the inception of the Revolving Working Capital Loan Facility, the borrowing bore an interest rate per annum equal to the LIBOR plus the applicable margin of 3.5% per annum. Effective March 31, 2023, borrowings under the Revolving Working Capital Loan Facility bore interest at a rate per annum equal to the SONIA plus the applicable margin of 3.5%.

The maturity of the Revolving Working Capital Loan Facility has since been extended on various dates subject to compliance with financial covenants. On May 10, 2024 the maturity was further extended to August 31, 2025. During the nine months ended September 30, 2024, the Company has repaid outstanding amount of $5.1 million under the 2020 Credit Agreement and accordingly wrote off the unamortized balance of less than $0.1 million of debt issuance cost related to the 2020 Credit Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2020 Credit Agreement. As of December 31, 2023, the Revolving Working Capital Loan Facility had an outstanding principal balance of $5.1 million.

As of December 31, 2023, the UK Subsidiary was in compliance with all affirmative and negative covenants under the 2019 Credit Agreement, including any financial covenants, pertaining to its financing arrangements.

2022 Committed Facility Agreement

In May 2022, the UK Subsidiary entered into a committed facility agreement (the “2022 Committed Facility Agreement”) with HSBC, which includes a term loan for £1.4 million to be used in refinancing a property owned by XBP Europe in Dublin, Ireland (the “Property”). At inception of the 2022 Committed Facility Agreement, the borrowing bore an interest rate equal to 3.5% per annum in addition to the Bank of England Base Rate. The maturity of the 2022 Committed Facility Agreement is May 2027. During the nine months ended September 30, 2024, the Company has repaid outstanding amount of $1.4 million under the 2022 Committed Facility Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2022 Committed Facility Agreement. As of December 31, 2023, the 2022 Committed Facility Agreement had an outstanding balance of $1.5 million.

The 2022 Committed Facility Agreement contains financial covenants including, but not limited to (a) a Combined Debt Service Coverage Ratio, which measures the cashflow less dividends, net capital expenditure, and taxation relative to the debt service for that relevant period, (b) interest cover, which measures EBITDA relative to the aggregate of (i) interest charges and (ii) interest element of finance leases in any relevant period, (c) Total Net Debt to EBITDA, which measures the total net debt relative to EBITDA for any relevant period, and (d) loan to market value, which measures the loan as a percentage of the aggregate market value of the Property. The term “Combined” refers to the UK subsidiary and its wholly-owned subsidiaries.

22

As of December 31, 2023, the UK Subsidiary was in compliance with all affirmative and negative covenants under the 2022 Committed Facility Agreement, including any financial covenants pertaining to its financing arrangements.

2024 Facilities Agreement

In June 2024, XBP Europe, Inc. a wholly-owned subsidiary of the Company, together with certain other subsidiaries (the “XBP Group”), entered into a Facilities Agreement (the “2024 Facilities Agreement”) with HSBC for a £15.0 million and €10.5 million Secured Credit Facility consisting of (i) a single draw, secured Term Loan A facility in an aggregate principal amount of £3.0 million (the “2024 Term Loan A Facility”), (ii) a single draw, secured Term Loan B facility in an aggregate principal amount of €10.5 million (the “2024 Term Loan B Facility”, collectively with the 2024 Term Loan A Facility, the “2024 Term Loan Facilities”) and (iii) a multi-draw, multi-currency secured revolving credit facility in an aggregate principal amount of £12.0 million (the “2024 Revolving Credit Facility”), and, together with the 2024 Term Loan Facilities, (the “2024 Senior Credit Facilities”). The 2024 Term Loan Facilities mature on June 26, 2028 and the 2024 Revolving Credit Facility matures on June 26, 2027, with certain extension rights at the discretion of HSBC. An additional £14.0 million of credit under the 2024 Revolving Credit Facility may be made available at HSBC’s discretion for specific purposes as per the 2024 Facilities Agreement.

The Company used the 2024 Term Loan Facilities to repay in full all outstanding indebtedness under the 2019 Credit Agreement, 2020 Credit Agreement and 2022 Committed Facility Agreement. The Company incurred $1.6 million in debt issuance costs related to the 2024 Facilities Agreement.

The 2024 Facilities Agreement contains financial covenants including, but not limited to, (i) requiring the maintenance of a consolidated total leverage ratio of not greater than 2.50 to 1.00 (with step-downs to (a) 2.25 to 1.00 starting January 1, 2025 and (b) 2.00 to 1.00 starting January 1, 2026); (ii) a cash flow coverage ratio of at least 1.10:1.00; and (iii) a consolidated interest coverage ratio of not less than 4.00 to 1.00.

The 2024 Facilities Agreement and indenture governing the 2024 Secured Credit Facilities contains certain affirmative and negative covenants limiting on the ability of the XBP Group to effect mergers and change of control events as well as certain other limitations, including limitations on (i) incurrence of additional indebtedness or liens, (ii) dispositions of assets, (iii) substantial changes of the general nature of the business, (iv) entering into restrictive agreements, (v) making certain investments, loans, advances, guarantees and acquisitions, (vi) prepaying certain indebtedness, (vii) the declaration and payment of dividends or other restricted payments, (viii) engaging in transactions with affiliates, or (ix) amending certain material documents.

Except as otherwise provided by applicable law, all obligations under the 2024 Facilities Agreement are jointly and severally unconditionally guaranteed by each member of the XBP Group.

Borrowings under the 2024 Term Loan A Facility, the 2024 Term Loan B Facility and 2024 Revolving Credit Facility bear interest at a rate per annum equal to the SONIA plus the applicable margin of 3.25%, Euro Interbank Offered Rate (“EURIBOR”) plus the applicable margin of 3.25% and Reference Rate plus the applicable margin of 3.25%, respectively. “Reference Rate” for any period means (i) Secured Overnight Financing Rate (“SOFR”) for funds extended in U.S. Dollars; (ii) the EURIBOR, for funds extended in Euros; (iii) the SONIA, for funds extended in Pounds Sterling; and the Stockholm Interbank Offered Rate (“STIBOR”) for funds extended in Swedish Krona.

During the nine months ended September 30, 2024, the Company has drawn $3.9 million under 2024 Term Loan A Facility and $11.4 million under 2024 Term Loan B Facility, and repaid $8.2 million outstanding indebtedness under the 2019 Credit Agreement, $5.1 million outstanding indebtedness under the 2020 Credit Agreement and $1.4 million outstanding indebtedness under the 2022 Committed Facility Agreement. Accordingly, the Company wrote off the unamortized balance of less than $0.1 million of debt issuance costs related to the 2019 Credit Agreement and 2020 Credit Agreement.

During the three and nine months ended September 30, 2024, the Company repaid $0.2 million and $0.6 million of outstanding principal amount under the 2024 Term Loan A Facility and 2024 Term Loan B Facility, respectively. As

23

of September 30, 2024, the outstanding balance of the 2024 Term Loan A Facility and the 2024 Term Loan B Facility was $3.8 million and $11.1 million, respectively. The principal amount drawn under the 2024 Term Loan A Facility shall be repaid in fifteen (15) equal quarterly installments of £150 thousands with the remaining outstanding principal amount of £750 thousands payable at maturity along with accrued and unpaid interest. The principal amount drawn under the 2024 Term Loan B Facility shall be repaid in fifteen (15) equal quarterly installments of €525 thousands with the remaining outstanding principal amount of €2.625 million payable at maturity along with accrued and unpaid interest.

As of September 30, 2024, the Company has drawn £12.0 million under 2024 Revolving Credit Facility in Euros currency. As of September 30, 2024, the outstanding balance under the 2024 Revolving Credit Facility was $15.8 million.

The Company may, at any time, prepay the principal of the 2024 Senior Credit Facilities. Each prepayment shall be accompanied by the payment of accrued interest, without any premium or penalty. However, the Company is limited to a maximum of four voluntary prepayments of the 2024 Revolving Credit Facility within any consecutive twelve-month period.

As of September 30, 2024, the XBP Group was in compliance with all affirmative and negative covenants under the 2024 Facilities Agreement, including any financial covenants, pertaining to its financing arrangements. The Company continually monitors its compliance with such covenants. The Company believes it will remain in compliance with all such covenants for the next twelve months; however, due to the inherent uncertainty, management’s estimates of the achievement of its financial covenants may change in the future.

Debt Outstanding

As of September 30, 2024, and December 31, 2023, the following debt instruments were outstanding:

September 30, 

December 31, 

(dollars in thousands)

    

2024

    

2023

2024 Term Loan A Facility(1)

$

3,602

$

2024 Term Loan B Facility(2)

10,511

Term loan

3,785

2024 Revolving Credit Facility(3)

15,217

Revolvers(4)

2,123

12,767

Secured borrowings under Securitization Facility

 

 

74

Total debt

 

31,453

 

16,626

Less: Current portion of long-term debt

 

5,047

 

3,863

Long-term debt, net of current maturities

$

26,406

$

12,763

(1)Net of unamortized debt issuance costs of $0.2 million as of September 30, 2024.
(2)Net of unamortized debt issuance costs of $0.6 million as of September 30, 2024.
(3)Net of unamortized debt issuance costs of $0.6 million as of September 30, 2024.
(4)Includes $2.1 million and $1.3 million of outstanding balance under working capital loan as of September 30, 2024 and December 31, 2023, respectively.

11.Income Taxes

The Company applies an estimated annual effective tax rate (“ETR”) approach for calculating tax provision for interim periods, as required under GAAP. The Company recorded an income tax expense of $1.7 million and $1.0 million for the three months ended September 30, 2024 and 2023, respectively, and $2.7 million and $1.5 million for the nine months ended September 30, 2024 and 2023, respectively, from continuing operations.

The Company’s ETR from continuing operations of 380.6% and (89.8)% for three and nine months ended September 30, 2024, respectively, differed from the expected U.S. statutory tax rate of 21.0% and was primarily

24

impacted by uncertain tax benefits, permanent tax adjustments, foreign tax rates that differ from the U.S. federal statutory rate, valuation allowances on a portion of the Company’s foreign deferred tax assets that are not more likely than not to be realized and remeasurement of existing uncertain tax positions.

For the three and nine months ended September 30, 2023, the Company’s ETR from continuing operations of (604.6)% and 1,450.5%, respectively, differed from the expected U.S. statutory tax rate of 21.0%, and was primarily impacted by permanent tax adjustments, foreign tax rates that differ from the U.S. federal statutory rate, and valuation allowances on a portion of the Company’s foreign deferred tax assets that are not more likely than not to be realized.

During the nine months ended September 30, 2024, the Company's liability for unrecognized tax benefits (including interest and penalties) increased by $0.7 million. This increase is primarily due to remeasurement of existing uncertain tax positions in Germany. The Company believes that adequate provision has been made for any adjustments that may result from the ongoing tax examination in Germany. However, the outcome of such tax examinations cannot be predicted with certainty. If any issues addressed in the Company’s tax examinations are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Any significant change in the amount of the Company’s liability for unrecognized tax benefits would most likely result from additional information or settlements relating to the examination of the Company’s tax returns in Germany.

As of September 30, 2024, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2023.

12.Employee Benefit Plans

U.K. Pension Plan

Two of the Company’s subsidiaries in the United Kingdom provide pension benefits to certain retirees and eligible dependents. Employees eligible for participation included all full-time regular employees who were more than three years from retirement prior to October 2001. A retirement pension or a lump-sum payment may be paid dependent upon length of service at the mandatory retirement age. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants at the earlier of two dates, the participants leaving the Company or March 31, 2015. The expected rate of return assumptions for plan assets relate solely to the UK plan and are based mainly on historical performance achieved over a long period of time (15 to 20 years) encompassing many business and economic cycles.

German Pension Plan

XBP Europe’s subsidiaries in Germany, Exela Technologies ECM Solutions GmbH, provides pension benefits to certain retirees. Employees eligible for participation include all employees who started working for the Company or its predecessors prior to September 30, 1987 and have finished a qualifying period of at least 10 years. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. The German pension plan is an unfunded plan and therefore has no plan assets. No new employees are registered under this plan and the participants who are already eligible to receive benefits under this plan are no longer employees of the Company.

Norway Pension Plan

The Company’s subsidiary in Norway provides pension benefits to eligible retirees and eligible dependents. Employees eligible for participation include all employees who were more than three years from retirement prior to March 2018. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are

25

registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants at the earlier of two dates, the participants leaving the Company or April 30, 2018.

Asterion Pension Plan

In 2018, Exela Technologies Holding GmbH (through the Asterion Business Combination), acquired the obligation to provide pension benefits to eligible retirees and eligible dependents. Employees eligible for participation included all full-time regular employees who were more than three years from retirement prior to July 2003. A retirement pension or a lump-sum payment may be paid dependent upon length of service at the mandatory retirement age. The Company accrues the cost of these benefits over the service lives of the covered employees based on an actuarial calculation. The Company uses a December 31 measurement date for this plan. No new employees are registered under this plan and the pension obligation for the existing participants of the plan is calculated based on actual salary of the participants at the earlier of two dates, the participants leaving the Company or April 10, 2018.

Tax Effect on Accumulated Other Comprehensive Loss

As of September 30, 2024, and December 31, 2023, the Company had actuarial gain of $1.0 million and $0.2 million, respectively, which is net of a deferred tax benefit of $1.3 million for each period.

Pension and Postretirement Expense

The components of the net periodic benefit cost are as follows:

Three months ended September 30, 

Nine months ended September 30, 

(dollars in thousands)

    

2024

    

2023

    

2024

    

2023

Service cost

$

9

$

10

$

28

$

30

Interest cost

 

761

 

779

 

2,243

 

2,298

Expected return on plan assets

 

(748)

 

(693)

 

(2,203)

 

(2,045)

Amortization

Amortization of prior service cost

 

 

90

 

 

268

Amortization of net loss

 

313

 

403

 

925

 

1,186

Net periodic benefit cost

$

335

$

589

$

993

$

1,737

The Company records pension interest cost within interest expense, net. Expected return on plan assets, amortization of prior service costs, and amortization of net losses are recorded within pension income, net. Service cost is recorded within cost of revenue.

Employer Contributions

XBP Europe’s funding of employer contributions is based on governmental requirements and differs from those methods used to recognize pension expense. The Company made contributions of $1.1 million and $0.6 million to its pension plans during the three months ended September 30, 2024 and 2023, respectively, and $1.3 million and $1.9 million for the nine months ended September 30, 2024 and 2023, respectively. The Company has plans to fund the pension plans with the required contributions for 2024 based on current plan provisions.

13.Commitments and Contingencies

Litigation

The Company is, from time to time, involved in certain legal proceedings, inquiries, claims and disputes, which arise in the ordinary course of business. Although management cannot predict the outcomes of these matters, management does not believe these actions will have a material, adverse effect on our condensed consolidated balance sheets, condensed consolidated statements of operations or condensed consolidated statements of cash flows.

26

Company Subsidiary Litigation

A group of 71 former employees brought a claim against a subsidiary of XBP Europe related to their dismissal resulting from the closure of two production sites in France in 2020. The employees filed complaints with the Labor Court on June 9, 2022. Conciliation hearings at the Labor Court were held on September 27, 2022, December 13, 2022, March 7, 2023, September 5, 2023 and November 14, 2023.

In March 2023, 67 claimants (after the in principle settlement was agreed with the first 4 claimants) filed an application for summary proceedings in respect of part of the claim for a total claim of $1.1 million. The summary proceedings hearing was held on April 11, 2023 and the court issued its decision on May 9, 2023 upholding all of the plaintiffs’ claims for a total amount of $1.1 million, however the court’s decision does not increase the Company’s anticipated exposure for the overall claim.

The Company has appealed against the decision (and paid the amount of $1.1 million on November 10, 2023 pending the appeal), the appeal hearing was scheduled for September 9, 2024 and was held on November 4, 2024. The next hearing, pertaining only to 15 remaining claimants who have not concluded settlement agreements with the Company, is scheduled for January 13, 2025.

The substantive hearing was held on February 16, 2024 and a decision was made at the end of June 2024.

The Company reached a number of settlements with a certain number of claimants prior to the decision of the court and approximately $1.8 million was paid to such claimants in addition to the amounts paid as part of the summary proceedings. The court awarded $1.2 million to the claimants who had not settled before the court’s decision and, after the deduction of the amounts already paid to such claimants, $1.0 million remain to be paid by the Company. The Company will also be responsible for up to three months’ unemployment allowance paid to these claimants by the unemployment fund, which is not expected to significantly increase the Company’s total costs. The Company has appealed the decision. The Company accrued $1.1 million and $2.2 million in accrued liabilities on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023, respectively, based on the estimate of the range of possible losses.

Contract-Related Contingencies

The Company has certain contingent obligations that arise in the ordinary course of providing services to its customers. These contingencies are generally the result of contracts that require the Company to comply with certain performance measurements or the delivery of certain services to customers by a specified deadline. The Company believes the adjustments to the transaction price, if any, under these contract provisions will not result in a significant revenue reversal or have a material adverse effect on the Company’s condensed consolidated balance sheets, condensed consolidated statements of operations, condensed consolidated statement of comprehensive loss or condensed consolidated statements of cash flows.

14.Fair Value Measurement

Fair Value of Financial Instruments

The carrying amount of assets and liabilities including cash and cash equivalents, accounts receivable, accounts payable and current portion of long-term debt approximated their fair value as of September 30, 2024 and December 31, 2023, due to the relative short maturity of these instruments. The fair values of the Company’s loans and receivables under the factoring arrangement entered into by subsidiaries of the Company are equal to the carrying values. Property and equipment, intangible assets, capital lease obligations, and goodwill are not required to be re-measured to fair value on a recurring basis. These assets are evaluated for impairment if certain triggering events occur. If such evaluation indicates that impairment exists, the respective asset is written down to its fair value.

As of September 30, 2024 and December 31, 2023, the Company determined the fair value of Private Warrants’ liability as $0.0 million and less than $0.1 million, respectively, included in the other long-term liabilities in the

27

condensed consolidated balance sheets under Level 3 fair value measurement using the Black-Scholes option pricing model.

The significant unobservable inputs used in the fair value of the Private Warrants liability are assumptions related to the inputs of exercise price, fair value of the underlying common stock, risk-free interest rate, expected term, expected volatility, and expected dividend yield. Significant increases (decreases) in the discount rate would have resulted in a lower (higher) fair value measurement. Significant increases (decreases) in the forecasted financial information would have resulted in a higher (lower) fair value measurement. For all significant unobservable inputs used in the fair value measurement of the Level 3 liabilities, a change in one of the inputs would not necessarily result in a directionally similar change in the fair value.

The following table reconciles the beginning and ending balances of net assets and liabilities classified as Level 3:

September 30, 

(dollars in thousands)

2024

Balance at beginning of period

$

50

Change in the fair value of the private warrants liability

 

(45)

Balance at end of period

$

5

15.Stock-Based Compensation

XBP Europe 2024 Stock Incentive Plan

On June 13, 2024, the stockholders of XBP Europe approved and adopted XBP Europe’s 2024 Stock Incentive Plan (the “XBP 2024 Equity Plan”) at XBP Europe’s 2024 Annual Meeting of Stockholders. Under the XBP 2024 Equity Plan, subject to adjustment for certain changes in capitalization or other corporate events, XBP Europe is authorized to issue up to 5,520,270 shares of common stock pursuant to equity-based awards, which may be granted to eligible participants in furtherance of XBP Europe’s broader compensation strategy and philosophy. Awards granted under the 2024 Equity Plan will be granted upon terms approved by XBP Europe’s Compensation Committee and set forth in an award agreement or other evidence of an award. As of September 30, 2024, there were no shares of XBP Europe’s common stock issued under the XBP 2024 Equity Plan. However, restricted stock unit and stock options were issued under the XBP 2024 Equity Plan.

Restricted Stock Unit

Restricted stock unit awards generally vest ratably over a less than a year to three (3) year period. Restricted stock units are subject to forfeiture if employment or service terminates prior to vesting and are expensed ratably over the vesting period.

A summary of restricted stock unit activities under the XBP 2024 Equity Plan for the nine months ended September 30, 2024 is summarized in the following table:

Average

Weighted

Remaining

Number

Average Grant

Contractual Life

    

of Units

    

Date Fair Value

    

(Years)

Granted

 

3,325,329

$

1.24

Forfeited

 

 

Vested

 

 

Outstanding Balance as of September 30, 2024

3,325,329

$

1.24

 

2.44

28

Options

Under the XBP 2024 Equity Plan, stock options are granted at a price per share not less than 100% of the fair market value per share of the underlying stock at the grant date. The vesting period for each option award is established on the grant date, and the options generally expire ten (10) years from the grant date. Stock options granted under the 2024 Plan generally require no less than a four (4) year ratable vesting period. Stock option activity for the nine months ended September 30, 2024 is summarized in the following table:

Average

Weighted

Weighted

Remaining

Average Grant

Average

Vesting Period

    

Outstanding

    

Date Fair Value

    

Exercise Price

    

(Years)

Granted

 

95,000

 

$

0.58

 

$

Exercised

 

Forfeited

 

Expired

Outstanding Balance as of September 30, 2024(1)

 

95,000

 

$

0.58

 

$

1.31

 

3.58

(1)None of the outstanding options are exercisable as of September 30, 2024. Exercise prices of all of the outstanding options as of September 30, 2024 were higher than the market price of the shares of the Company. Therefore, aggregate intrinsic value was zero.

As of September 30, 2024, there was $3.3 million of total unrecognized compensation expense related to non-vested restricted stock unit awards and stock option awards under the XBP 2024 Equity Plan, which will be recognized over the respective service period. Stock-based compensation expense is recorded within selling, general, and administrative expenses. The Company incurred total compensation expense of $0.7 million and $0.9 million related to restricted stock unit awards and stock option awards under the XBP 2024 Equity Plan for the three and nine months ended September 30, 2024, respectively.

16.Warrants

As of September 30, 2024, the Company had the following common stock warrants outstanding:

    

Warrants

    

Exercise  Price

    

Issuance Date

    

Expiration

Private Placement Warrants

 

135,000

 

11.50

 

3/11/2021

 

11/29/2028

Forward Purchase Warrants

 

250,000

 

11.50

 

3/11/2021

 

11/29/2028

Public Warrants

 

6,249,980

 

11.50

 

3/11/2021

 

11/29/2028

Total

 

6,634,980

 

  

 

  

 

  

Public Warrants

The Public Warrants qualify for the derivative scope exception under ASC 815 and are therefore classified as equity on the condensed consolidated balance sheets. They may only be exercised for a whole number of shares at a price of $11.50. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants are currently exercisable and will expire five years from the completion of the Business Combination or earlier upon redemption or liquidation.

The Company may redeem the outstanding Public Warrants if the price per share of common stock equals or exceeds $18.00 (except as described with respect to the Private Placement Warrants and Forward Purchase Warrants):

in whole and not in part;
at a price of $0.01 per Warrant;

29

upon not less than 30 days prior written notice of redemption to each warrantholder; and
if, and only if, the closing price of the Common stock equals or exceeds $18.00 per share (as adjusted) for any of 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending three trading days before the Company sends the notice of redemption to the warrantholders.

If and when the Public Warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares of Common Stock upon exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification.

Private Warrants

The Private Warrants meet the definition of a derivative, however they don’t meet the equity scope exception in ASC 815 and are therefore classified as a liability. The Private Warrants are identical to the Public Warrants, except that so long as they are held by Cantor or any Permitted Transferees, as applicable, the Private Warrants (i) may be exercised for cash or on a cashless basis, (ii) may not be transferred, assigned or sold until thirty (30) days after the completion by the Company of an initial Business Combination, and (iii) shall not be redeemable by the Company,

Upon exercise of each of the Public Warrants and Private Warrants, the exercise price and number of shares of Common Stock issuable may be adjusted in certain circumstances including in the event of a stock dividend, a consolidation, combination, reverse stock split or reclassification of shares of Common Stock.

17.Stockholders’ Deficit

Preferred Stock — The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.0001 per share. As of September 30, 2024, there were no shares of preferred stock issued or outstanding.

Common Stock — The Company is authorized to issue 200,000,000 shares of common stock with a par value of $0.0001 per share. Each holder of Common Stock will be entitled to one (1) vote in person or by proxy for each share of the Common Stock. The holders of shares of Common Stock will not have cumulative voting rights. As of September 30, 2024, there were 30,166,102 shares of Common stock issued and outstanding, respectively.

18.Restructuring

The Company periodically takes actions to improve operating efficiencies, typically in connection with rationalizing the cost structure of the Company. The Company’s footprint and headcount reductions and organizational integration actions relate to discrete, unique restructuring events, primarily reflected in approved plans for reductions in force.

In the fourth quarter of 2023, the Company’s management approved a restructuring plan to realign the Company’s business and strategic priorities by rightsizing its workforce in certain regions.

The Company’s restructuring activity and balance of the restructuring liability is as follows:

    

September 30, 

    

December 31, 

(dollars in thousands)

2024

    

2023

Balance at beginning of the period

$

5,267

$

2,036

Restructuring charges

 

558

 

4,297

Payment of benefits

 

(4,303)

 

(1,066)

Balance at end of the period

$

1,522

$

5,267

30

As of September 30, 2024 and December 31, 2023, the current portion of the restructuring liability was $1.5 million and $5.3 million respectively, and was included in accrued compensation and benefits in the condensed consolidated balance sheets.

19.Related Parties

The components of related party expense in the condensed consolidated statements of operations are summarized as follows:

    

Three months ended

    

Nine months ended

September 30, 

September 30, 

(dollars in thousands)

2024

    

2023

2024

    

2023

Related party shared services

$

858

$

984

$

2,441

$

2,760

Related party royalty

 

 

209

 

 

432

Related party service fee

 

563

 

123

 

1,086

 

397

Total related party expense

$

1,421

$

1,316

$

3,527

$

3,589

Historically, the Company has been managed and operated in the ordinary course of business with other affiliates of ETI. Accordingly, certain shared costs have been allocated to the Company and reflected as expenses in the condensed consolidated financial statements.

Sales of Products and Services

During the historical periods presented, the Company sold products and services to non-XBP Europe subsidiaries of ETI. Revenue, net in the condensed consolidated statements of operations include sales to affiliates of ETI of less than $0.1 million and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and $0.2 million and $0.2 million for the nine months ended September 30, 2024 and 2023, respectively.

Purchases

During the historical periods presented, the Company purchased high-speed scanners and related products from non-XBP Europe subsidiaries of ETI. These purchases totaled $0.1 million and $0.0 million for the three months ended September 30, 2024 and 2023, respectively, and $0.1 million and $1.0 million for the nine months ended September 30, 2024 and 2023, respectively.

Shared Service Center Costs

The historical costs and expenses reflected in our financial statements include costs for certain shared service functions historically provided by the non-XBP Europe subsidiaries of the Company’s parent, ETI, including, but not limited to accounting and finance, IT and business process operations. Where possible, these charges were allocated based on full-time equivalents (FTE’s), formal agreements between XBP Europe and subsidiaries of ETI, or other allocation methodologies that Management determined to be a reasonable reflection of the utilization of services provided or the benefit received by XBP Europe and all costs of operating XBP Europe during the periods presented.

The allocated shared service expenses and general corporate expenses incurred pursuant to the Services Agreement for the three months ended September 30, 2024 and 2023 were $0.8 million and $1.0 million, respectively, and $2.4 million and $2.8 million for the nine months ended September 30, 2024 and 2023, respectively, and are included in the related party expenses in the condensed consolidated statements of operations.

In the opinion of management of ETI and the Company, the expense and cost allocations have been determined on a basis considered to be a reasonable reflection of the utilization of services provided or the benefit received by the Company during 2024 and 2023. The amounts that would have been, or will be incurred, on a stand-alone basis could differ from the amounts allocated due to economies of scale, difference in management judgment, a requirement for more or fewer employees or other factors. Management does not believe, however, that it is practicable to estimate what

31

these expenses would have been had the Company operated as an independent entity, including any expenses associated with obtaining any of these services from unaffiliated entities. In addition, the future results of operations, financial position and cash flows could differ materially from the historical results presented herein.

Royalty Expenses

During the historical periods presented, subsidiaries of the Company’s parent, ETI, charged royalty fees for allowing the Company to use tradenames and trademarks owned by subsidiaries of ETI. The Company incurred royalty expense of $0 and $0.2 million for the three months ended September 30, 2024 and 2023, respectively, and $0 and $0.4 million for the nine months ended September 30, 2024 and 2023, respectively, included in related party expense within the condensed consolidated statements of operations.

Service Fee

During the historical periods presented, subsidiaries of ETI provided management services to the Company in exchange for a management fee. These management services included provision of legal, human resources, corporate finance, and marketing support. The management fee was calculated based on a weighted average of total external revenue, headcount and total assets attributable to the Company. On October 9, 2022 the management fee was terminated when the Merger Agreement was entered into and was replaced by the related party service fee pursuant to the Services Agreement, which reduced the fee and modified the services provided. Services provided under Annex A of the Services Agreement include sales of certain hardware, operations delivery, finance, accounting, human resource and technology support services. The Company incurred total fees of $0.6 million and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and $1.1 million and $0.4 million for the nine months ended September 30, 2024 and 2023, respectively.

Note Receivable

The Company entered into an Intercompany Loan Agreement with an affiliate of ETI on January 1, 2016, where the Company agreed to lend up to €20 million to the affiliate. The related party note receivable had a six year term with the option to extend for an additional one year term and bore annual interest of 9.5%, due at the end of the term. On January 1, 2023, the Company amended its Intercompany Loan Agreement, extending the maturity of the Intercompany Loan Agreement to December 31, 2023. In accordance with the Ultimate Parent Support Agreement, related party note receivable was eliminated at Closing against related party payables with a residual amount recorded to additional paid-in capital. No related party note receivable was recorded in the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023. The condensed consolidated statements of operations included $0 and $0.3 million of related party interest income for the three months ended September 30, 2024 and 2023, respectively, and $0 and $1.0 million for the nine months ended September 30, 2024 and 2023, respectively.

Notes Payable

The Company entered into three Intercompany Loan Agreements with an affiliate of ETI, in September 2009 and May 2010, whereby the affiliate of ETI agreed to lend up to £9.3 million to the Company (“related party notes payable”). The related party notes payable which were denominated in Great British pounds accrued interest daily at the one-month LIBOR rate for United States dollar deposits in the London interbank market plus four percentage points. These notes had an original maturity date of one year (which was extended by the lender for one additional year on each anniversary of the notes) and were assigned by the lender to another affiliate of ETI and amended with an effective date of December 1, 2012. The amendment amended (a) the interest rate to a fixed rate of 4% plus LIBOR for the remainder of 2012, 12% for 2013 and 13.5% thereafter, (b) extended the term of the agreement to December 31, 2024, and (c) denominated the notes in United States dollars. In accordance with the Ultimate Parent Support Agreement, related party notes payable were eliminated at closing with a corresponding impact to additional paid-in capital. As a result, no related party notes payable was recorded in the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023. The condensed consolidated statements of operations included related party interest expense of $0 and $0.4 million for the three months ended September 30, 2024 and 2023, respectively, and $0 and $1.1 million for the nine months ended September 30, 2024 and 2023, respectively, in the related party interest expense (income), net.

32

Further, the Company entered into another four Intercompany Loan Agreements (“new related party notes payable”) with affiliates of ETI, three of the notes are dated September 4, 2023 (and subsequently amended on September 15, 2023) and one note is dated September 15, 2023. The new related party notes payable have a ten year term and bear annual interest of 6.0%, due at the end of the term. The condensed consolidated balance sheets included $1.6 million and $1.5 million new related party notes payable as of September 30, 2024 and December 31, 2023, respectively. The condensed consolidated statements of operations included less than $0.1 million and $0.1 million of related party interest expense for the three and nine months ended September 30, 2024, respectively, in the related party interest expense (income), net.

Related Party Payables and Related Party Notes Payables Balances with Affiliates

Related party payables and related party notes payables balances with affiliates as of September 30, 2024 and December 31, 2023 were as follows:

September 30, 2024

December 31, 2023 

(dollars in thousands)

Related party payables

    

Related party notes payable

Related party payables

    

Related party notes payable

ETI

$

5,523

$

1,559

$

13,350

$

1,542

20.Segment Information

The Company’s operating segments are significant strategic business units that align its products and services with how it manages its business, approaches the markets and interacts with its clients. The Company is organized into two segments: Bills and Payments and Technology.

Bills and Payments

The Bills & Payments business unit primarily focuses on optimizing how bills and payments are processed by businesses of all sizes and industries. It offers automation of Accounts Payable (“AP”) and Accounts Receivables (“AR”) processes and through its platform, XBP, seeks to integrate buyers and suppliers across Europe. This business unit also includes our digital transformation revenue, which is both project based and recurring.

Technology

The Technology business unit primarily focuses on sales of recurring software licenses and related maintenance, hardware solutions and related maintenance and professional services.

33

The chief operating decision maker reviews segment profit to evaluate operating segment performance and determine how to allocate resources to operating segments. “Segment profit” is defined as revenue less cost of revenue (exclusive of depreciation and amortization). The Company does not allocate selling, general, and administrative expenses, depreciation and amortization, interest expense and foreign exchange losses, net. The Company manages assets on a total company basis, not by operating segment, and therefore asset information and capital expenditures by operating segments are not presented.

In accordance with applicable accounting guidance, the results of the disposable group are presented as discontinued operations in the condensed consolidated statements of operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. See Note 3 - Discontinued Operations of the notes to condensed consolidated financial statements.

A reconciliation of segment profit to net loss before income taxes is presented below.

    

Three months ended September 30, 2024

(dollars in thousands)

Bills & Payments

    

Technology

    

Total

Revenue, net (including related party revenue of $0.1 million)

$

24,555

$

10,845

$

35,400

Cost of revenue (including related party cost of revenue of $0.0 million, exclusive of depreciation and amortization)

 

19,402

 

4,446

 

23,848

Segment profit

 

5,153

 

6,399

 

11,552

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

  

 

6,818

Related party expense

 

  

 

1,421

Depreciation and amortization

 

  

 

804

Interest expense, net

 

  

 

1,820

Related party interest expense, net

 

  

 

23

Foreign exchange losses, net

 

  

 

668

Changes in fair value of warrant liability

 

  

 

(5)

Pension income, net

 

  

 

(435)

Net income before income taxes

 

  

$

438

    

Three months ended September 30, 2023

(dollars in thousands)

Bills & Payments

    

Technology

    

Total

Revenue, net (including related party revenue of $0.1 million)

$

25,344

$

12,152

$

37,496

Cost of revenue (including related party cost of revenue of $0.0 million, exclusive of depreciation and amortization)

 

22,604

 

5,637

 

28,241

Segment profit

 

2,740

 

6,515

 

9,255

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

  

 

6,846

Related party expense

 

  

 

1,316

Depreciation and amortization

 

  

 

745

Interest expense, net

 

  

 

1,246

Related party interest income, net

 

  

 

5

Foreign exchange gains, net

 

  

 

(530)

Pension income, net

 

  

 

(200)

Net loss before income taxes

 

  

$

(173)

34

    

Nine months ended September 30, 2024

(dollars in thousands)

Bills & Payments

    

Technology

    

Total

Revenue, net (including related party revenue of $0.2 million)

$

75,860

$

31,127

$

106,987

Cost of revenue (including related party cost of revenue of $0.0 million, exclusive of depreciation and amortization)

 

64,854

 

13,950

 

78,804

Segment profit

 

11,006

 

17,177

 

28,183

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

  

 

19,785

Related party expense

 

  

 

3,527

Depreciation and amortization

 

  

 

2,387

Interest expense, net

 

  

 

4,698

Related party interest expense, net

 

  

 

64

Foreign exchange losses, net

 

  

 

2,016

Changes in fair value of warrant liability

 

  

 

(45)

Pension income, net

 

  

 

(1,278)

Net loss before income taxes

 

  

$

(2,971)

    

Nine months ended September 30, 2023

(dollars in thousands)

Bills & Payments

    

Technology

    

Total

Revenue, net (including related party revenue of $0.2 million)

$

82,857

$

33,554

$

116,411

Cost of revenue (including related party cost of revenue of $0.1 million, exclusive of depreciation and amortization)

 

71,138

 

14,468

 

85,606

Segment profit

 

11,719

 

19,086

 

30,805

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

  

 

21,448

Related party expense

 

  

 

3,589

Depreciation and amortization

 

  

 

2,207

Interest expense, net

 

  

 

3,641

Related party interest income, net

 

  

 

(1)

Foreign exchange losses, net

 

  

 

405

Pension income, net

 

  

 

(589)

Net income before income taxes

 

  

$

105

35

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis together with our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q. Among other things, the condensed consolidated financial statements include more detailed information regarding the basis of presentation for the financial data than included in the following discussion. Amounts in thousands of United States dollars.

Unless otherwise indicated or the context otherwise requires, references in this section to “we,” “our,” “us,” “XBP Europe, “the Company” and similar terms are to XBP Europe Inc. and its subsidiaries before the Business Combination, and to XBP Europe Holdings, Inc. following consummation of the Business Combination, except where the context requires otherwise.

Unless otherwise noted, this Management’s Discussion and Analysis of Financial Condition and Results of Operations relates solely to our continuing operations and does not include the operations of our certain on-demand printing operations. See “Pending Divestiture” below and Note 3 - Discontinued Operations of the notes to condensed consolidated financial statements for additional information about the disposable group.

Forward Looking Statements

Certain statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this quarterly report are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for XBP Europe, and other statements that are not historical facts. These statements are based on the current expectations of XBP Europe management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties regarding XBP Europe’s businesses and actual results may differ materially. The factors that may affect our results include, among others: the impact of political and economic conditions on the demand for our services; cyber incidents such as a data or security breach; the impact of competition or alternatives to our services on our business pricing and other actions by competitors; our ability to address technological development and change in order to keep pace with our industry and the industries of our customers; the impact of terrorism, natural disasters or similar events on our business; the effect of legislative and regulatory actions in the United States and internationally; the impact of operational failure due to the unavailability or failure of third-party services on which we rely; the effect of intellectual property infringement; and other factors discussed in this quarterly report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”) under the heading “Risk Factors”, and otherwise identified or discussed in this quarterly report. You should consider these factors carefully in evaluating forward-looking statements and are cautioned not to place undue reliance on such statements, which speak only as of the date of this quarterly report. It is impossible for us to predict new events or circumstances that may arise in the future or how they may affect us. We undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this quarterly report. We are not including the information provided on any websites that may be referenced herein as part of, or incorporating such information by reference into, this quarterly report. In addition, forward-looking statements provide our expectations, plans or forecasts of future events and views as of the date of this quarterly report. We anticipate that subsequent events and developments may cause our assessments to change. These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this quarterly report.

Overview

The Company is a pan-European integrator of bills, payments and related solutions and services seeking to enable digital transformation of our clients. The Company serves over 2,000 clients of varying sizes and across multiple

36

industries and geographies. We believe our business ultimately advances digital transformation, improves market-wide liquidity, and encourages sustainable business practices.

The Company’s digital foundation was developed to deliver fully outsourced solutions to address current and evolving client needs. The Company hosts its products both on client premises and as a SaaS offering in the cloud. These offerings, along with several hybrid solutions are available to clients based on the client’s needs and preferences. When distributing its licenses, the Company offers a flexible model, whereby clients may choose among licenses covering a maximum number of transactions, multi-year term licenses with flexible renewal options, perpetual licenses, or per user subscriptions.

The Company’s primary source of revenue stems from transactions processed by its products, including bills and payments processing and constitutes the dominant part of revenue in our larger, Bills & Payments reporting segment. Other sources of revenue include the sale of recurring software licenses and professional services, perpetual software licenses, as well as hardware solutions and related maintenance and constitute our other, Technology reporting segment. The Company offers an industry-agnostic and cross-departmental suite of products, which center around finance and accounting (“F&A”) solutions and services comprised of the XBP Platform, Request to Pay, enterprise information management, Digital Mailroom, business process management and workflow automation, and integrated communication services. The Company also offers core industry solutions for the banking and financial services sector, and has, as a consequence of the COVID-19 pandemic, rolled out a suite of Work From Anywhere (“WFA”) applications with enterprise software for connectivity and productivity to enable remote work.

The continued success of the Company’s business is driven by its people. Its operation centers are located in areas where the value proposition the Company offers is attractive relative to other local opportunities, resulting in an engaged, educated multi-lingual workforce that is able to make a meaningful global contribution from their local marketplace. As of September 30, 2024, the Company had approximately 1,500 employees (of which 147 were part-time employees) across 16 countries (14 across Europe and in Morocco as well as the U.S., where our chief executive officer and chief financial officer are located).

History

XBP Europe, Inc. was incorporated in Delaware on September 28, 2022 to facilitate the Business Combination. On November 30, 2023, following the closing of the Business Combination, it became a wholly owned subsidiary of the Company, and the Company’s shares started trading on the Nasdaq Stock Market under the ticker “XBP” and its warrants started trading on the Nasdaq Stock Market under the ticker symbol “XBPEW”. Together with its subsidiaries, the Company constitutes a collection of entities, which have comprised the core European business of ETI since the 1995 merger between Texas-based BancTec, Inc. and Recognition International, Inc. The Company’s subsidiaries and predecessor entities have been serving clients in the European marketplace for over 45 years. In 2018, through the acquisitions of Asterion International and Drescher Full-Service Versand, ETI further expanded its geographic and client reach across Europe.

Pending Divestiture

As of September 30, 2024, certain on-demand printing operations of the Company met the criteria to be disclosed as discontinued operations in the third quarter of fiscal year 2024. See Note 3 - Discontinued Operations of the notes to condensed consolidated financial statements for additional information on discontinued operations.

Key Factors Affecting Company’s Business

The Company believes that its performance and future success depend upon several factors that present significant opportunities for us but also pose risks and challenges discussed in our 2023 Form 10-K under the heading “Risk Factors.”

37

Our Segments

Our two reportable segments are Bills & Payments and Technology. These segments are comprised of significant strategic business units that align our products and services with how we manage our business, approach our key markets and interact with our clients based on their respective industries.

Bills and Payments: The Bills & Payments business unit primarily focuses on optimizing how bills and payments are processed by businesses of all sizes and industries. The Company offers automation of AP and AR processes and through an integrated platform, seeks to integrate buyers and suppliers across Europe. This business unit also includes our digital transformation revenue, which is both project based and recurring.

Technology: The Technology business unit primarily focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions and related maintenance and professional services.

Key Performance Indicators

We use a variety of operational and financial measures to assess our performance. Among the measures considered by our management are the following:

Revenue by segment;
Gross profit by segment; and
Adjusted EBITDA (which is a non-GAAP financial measure).

Revenue by segment

We analyze our revenue by comparing actual monthly revenue to internal projections and prior periods across our operating segments in order to assess performance, identify potential areas for improvement, and determine whether segments are meeting management’s expectations.

Gross profit by segment

The Company defines Gross Profit as revenue less cost of revenue (exclusive of depreciation and amortization). The Company uses Gross Profit by segment to assess financial performance at the segment level.

Non-GAAP Financial Measures

To supplement its financial data presented on a basis consistent with GAAP, this report contains certain non-GAAP financial measures, including EBITDA and Adjusted EBITDA. The Company has included these non-GAAP financial measures because they are financial measures used by management to evaluate the Company’s core operating performance and trends, to make strategic decisions regarding the allocation of capital and new investments. These measures exclude certain expenses that are required under GAAP. The Company excludes these items because they are non-recurring or non-cash expenses that are determined based in part on the Company’s underlying performance.

EBITDA and Adjusted EBITDA

We define EBITDA as net income (loss), plus taxes, interest expense, and depreciation and amortization. We define Adjusted EBITDA as EBITDA plus restructuring and related expenses, related party management fee and royalties, foreign exchange gains or losses, changes in fair value of warrant liability, and non-recurring transaction costs incurred in connection with the Business Combination.

38

Note Regarding Non-GAAP Financial Measures

EBITDA and Adjusted EBITDA are not financial measures presented in accordance with GAAP. We believe that the presentation of these non-GAAP financial measures will provide useful information to investors in assessing our financial performance and results of operations as our board of directors and management use EBITDA and Adjusted EBITDA to assess our financial performance, because it allows them to compare our operating performance on a consistent basis across periods by removing the effects of our capital structure (such as varying levels of interest expense), asset base (such as depreciation and amortization) and items outside the control of our management team. Net income/loss is the GAAP measure most directly comparable to EBITDA and Adjusted EBITDA. Our non-GAAP financial measures should not be considered as alternatives to the most directly comparable GAAP financial measure. Each of these non-GAAP financial measures has important limitations as analytical tools because they exclude some but not all items that affect the most directly comparable GAAP financial measures. These non-GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP. Because EBITDA and Adjusted EBITDA may be defined differently by other companies in our industry, our definitions of these non-GAAP financial measures may not be comparable to similarly titled measures of other companies, thereby diminishing their utility.

The following tables present a reconciliation of EBITDA and Adjusted EBITDA to our net loss from continuing operations, the most directly comparable GAAP measure, for the three and nine months ended September 30, 2024 and 2023:

Three months ended

    

Nine months ended

September 30, 

September 30, 

(dollars in thousands)

2024

    

2023

    

2024

    

2023

Net loss from continuing operations

$

(1,226)

$

(1,219)

 

$

(5,637)

$

(1,418)

Income tax expense

1,664

 

1,046

2,666

 

1,523

Interest expense including related party interest expense, net

1,843

 

1,251

4,762

 

3,640

Depreciation and amortization

804

 

745

2,387

 

2,207

EBITDA from continuing operations

3,085

 

1,823

4,178

 

5,952

Restructuring and related expenses(1)

316

 

309

793

 

1,523

Employee litigation matter(2)

57

64

1,078

409

Related party management fee and royalties

 

334

 

1,131

Foreign exchange losses, net

668

 

(530)

2,016

 

404

Non-cash equity compensation(3)

725

885

Changes in fair value of warrant liability

(5)

(45)

Transaction Fees(4)

 

244

79

 

1,545

Adjusted EBITDA from continuing operations

$

4,846

$

2,244

$

8,984

$

10,964

(1)Adjustment represents costs associated with restructuring, including employee severance and vendor and lease termination costs.
(2)Represents litigation settlement and associated expenses incurred in connection with the Company subsidiary litigation. See Note 13 – Commitments and Contingencies for more details.
(3)Represents the non-cash charges related to restricted stock units and options.
(4)Represents transaction costs incurred as part of the Business Combination.

39

The following tables present a reconciliation of EBITDA and Adjusted EBITDA to our net loss from discontinuing operations, the most directly comparable GAAP measure, for the three and nine months ended September 30, 2024 and 2023:

Three months ended

    

Nine months ended

September 30, 

September 30, 

(dollars in thousands)

2024

    

2023

    

2024

    

2023

Net loss from discontinuing operations, net of income taxes

$

(1,543)

$

(1,668)

 

$

(4,063)

$

(4,533)

Income tax expense

72

72

Interest expense, net

3

 

19

18

 

64

Depreciation and amortization

135

 

350

432

 

744

EBITDA from discontinuing operations

(1,333)

 

(1,299)

(3,541)

 

(3,725)

Restructuring and related expenses(1)

 

 

76

Related party service fees and royalties

25

Impairment of goodwill

87

87

Foreign exchange losses, net

2

 

1

190

 

6

Adjusted EBITDA from discontinuing operations

$

(1,244)

$

(1,298)

$

(3,264)

$

(3,618)

(1)Adjustment represents costs associated with restructuring related to employee severance.

Key Components of Revenue and Expenses

Revenue

The Company earns revenue from transactions processed using its products and services. In addition, the Company also sells recurring and perpetual software licenses, as well as maintenance and other professional services. Licensing options are flexible and clients can purchase a license covering a maximum number of transactions, multi-year term licenses with flexible renewal options and per-user subscriptions. The Company derives a majority of its revenue from transactions processing as well as from the sale of licenses and technology implementation services.

Related party revenue — Related party revenue consists of sales of the above products or services to related parties.

Costs and Expenses

Cost of revenue — Cost of revenue consists primarily of salaries and employee benefits, including performance bonuses, facility costs and cost of products.

Related party cost of revenue — Related party cost of revenue consists of the cost of the products or services purchased or acquired from related parties, plus a related party transfer pricing markup.

Selling, general and administrative expenses — Selling, general and administrative expenses consist primarily of administrative personnel and officers’ salaries and benefits including performance bonuses, legal and audit expenses, insurance, operating lease expenses (mainly facilities and vehicles) and other facility costs.

Related party expenses — Related party expenses primarily consist of the shared service cost, service fee, royalties and related party management fee which was replaced by the related party service fee in connection with the Business Combination.

Depreciation and amortization — Depreciation and amortization of intangible assets expenses consist of depreciation of property and equipment and amortization of client relationship asset.

Interest expense, net — Interest expense consists of interest related to pensions, debt, and finance leases.

40

Related party interest expense — Related party interest expense consists of interest incurred on amounts due to related parties.

Foreign exchange losses, net — Foreign exchange losses, net is comprised of losses and gains due to foreign currency remeasurement that are netted together for reporting purposes.

Changes in fair value of warrant liability – Changes in fair value of warrant liability represents the mark-to-market fair value adjustments to the outstanding Private Warrants issued as part of the consummation of the Business Combination. The change in fair value of Private Warrants is primarily the result of the change in the underlying stock price of our stock used in the Black-Scholes option pricing model. The warrant is remeasured at the end of each subsequent reporting period.

Pension income, net — Pension income, net consists of expected return on employee benefit plan assets, amortization of prior service cost and amortization of net loss.

Income tax expense — Income taxes consist primarily of income taxes related to federal, and foreign jurisdictions in which the Company conducts its business. The Company maintains a full valuation allowance on net deferred tax assets for its U.S. federal taxes and certain foreign and state taxes as the Company has concluded that it is not more likely than not that the deferred assets will be utilized.

Results of Operations

Three months ended September 30, 2024 Compared to Three months ended September 30, 2023 (US dollars in thousands)

Three months ended September 30, 

    

2024

    

2023

Revenue:

 

  

 

  

Bills and Payments

$

24,555

$

25,344

Technology

 

10,845

 

12,152

Revenue, net (including related party revenue of $0.1 million and $0.1 million, respectively)

 

35,400

 

37,496

Cost of revenue:

 

 

  

Bills and Payments

 

19,402

 

22,604

Technology

 

4,446

 

5,637

Total cost of revenue (including related party cost of revenue of $0.0 million and $0.0 million, respectively, exclusive of depreciation and amortization)

 

23,848

 

28,241

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

6,818

 

6,846

Related party expense

 

1,421

 

1,316

Depreciation and amortization

 

804

 

745

Operating profit

 

2,509

 

348

Interest expense, net

 

1,820

 

1,246

Related party interest expense, net

 

23

 

5

Foreign exchange losses (gains), net

 

668

 

(530)

Changes in fair value of warrant liability

(5)

Pension income, net

 

(435)

 

(200)

Net income (loss) before income taxes

 

438

 

(173)

Income tax expense

 

1,664

 

1,046

Net loss from continuing operations

$

(1,226)

$

(1,219)

For the purposes of trend analysis, constant currency refers to the prevailing rate of the US dollar against relevant currencies for the quarter ended September 30, 2023.

41

Revenue

For the three months ended September 30, 2024, our net revenue on a consolidated basis decreased by $2.1 million, or 5.6%, to $35.4 million (including related party revenue of $0.1 million) from $37.5 million (including related party revenue of $0.1 million) for the three months ended September 30, 2023. On a constant currency basis, net revenue declined by $2.8 million or 7.4%, offset by the positive impact of foreign currency accounting for $0.7 million or 1.8%.

Bills & Payments and Technology segments constituted 69.4%, and 30.6%, respectively, of our total net revenue for the three months ended September 30, 2024, compared to 67.6%, and 32.4%, respectively, for the three months ended September 30, 2023. The revenue changes by reporting segment were as follows:

Bills & Payments — Net revenue attributable to bills and payments segment was $24.6 million for the three months ended September 30, 2024, compared to $25.4 million for the three months ended September 30, 2023. The revenue decline of $0.8 million or 3.1%, is primarily attributable to lower postage revenue, lower volumes and client contract ends, offset by the positive impact of newly won business, some of which is in early stage of ramp. On a constant currency basis, revenue declined by $1.2 million or 4.8%, offset by the positive impact of foreign currency accounting for $0.4 million or 1.7%.

Technology — For the three months ended September 30, 2024, net revenue attributable to the Technology segment decreased by $1.3 million or 10.8%, to $10.8 million from $12.1 million for the three months ended September 30, 2023. The revenue decline in the Technology segment was largely due to lower license sales offset by higher implementation and professional services revenue. On a constant currency basis, revenue decreased by $1.6 million or 12.8%, offset by the positive impact of foreign currency accounting for $0.3 million or 2.0%.

Cost of Revenue

For the three months ended September 30, 2024, the cost of revenue decreased by $4.4 million (including decrease in related party cost of $0.0 million), or 15.6%, compared to the three months ended September 30, 2023. Total cost of revenue decreased by $5.0 million or 17.7% on a constant currency basis, offset by the negative impact of foreign currency accounting for $0.6 million or 2.2%, when compared to the cost of revenue for the three months ended September 30, 2023.

In the Bills & Payments segments, the decrease was primarily attributable to reduced cost resulting from completed projects and optimization efforts. Costs to the Bills & Payments segment decreased by $3.2 million, or 14.2%. On a constant currency basis, cost of revenue at Bills & Payments segment declined by $3.7 million or 16.5%, offset by the negative impact of foreign currency accounting for $0.5 million or 2.4%.

The cost of revenue in the Technology segment decreased by $1.2 million, or 21.1%, primarily due to the change in the revenue mix within the Technology segment. On a constant currency basis, cost of revenue at the Technology segment decreased by $1.3 million or 22.5%, offset by the negative impact of foreign currency accounting for $0.1 million or 1.4%.

The decrease in cost of revenues as a percent of revenue on a consolidated basis was primarily due to a change in the revenue mix and executed savings initiative. Cost of revenue for the three months ended September 30, 2024 was 67.4% of revenue compared to 75.3% of revenue for the three months ended September 30, 2023.

Selling, General and Administrative Expenses

Selling, general and administrative expenses (“SG&A expenses”) slightly decreased by $28 thousand, or 0.4%, to $6.8 million for the three months ended September 30, 2024, compared to $6.8 million for the three months ended September 30, 2023. The decrease was primarily attributable by cost optimization initiatives, resulting in reduced operating lease and facility expenses, partially offset by increased investments in sales team for the three months ended September 30, 2024 compared to the three months ended September 30, 2023. SG&A expenses increased as

42

a percentage of revenue at 19.3% for the three months ended September 30, 2024 as compared to 18.3% for the three months ended September 30, 2023.

Related Party Expense

Related party expense was $1.4 million for the three months ended September 30, 2024 compared to $1.3 million for the three months ended September 30, 2023. The increase was primarily driven by the expansion of Center of Excellence (COE) during the current period, which involved consolidating financial processes to strengthen the controls framework.

Depreciation and Amortization

Total depreciation and amortization expense was $0.8 million and $0.7 million for the three months ended September 30, 2024 and 2023, respectively. The increase in total depreciation and amortization expense by $0.1 million was primarily due to an increase in amortization expense related to outsource contract costs during the three months ended September 30, 2024.

Interest Expense

Interest expense was $1.8 million for the three months ended September 30, 2024, compared to $1.2 million for the three months ended September 30, 2023, largely due to higher pension interest cost and an increase in borrowing costs due to an increase in relevant borrowing reference rates during the three months ended September 30, 2024 compared to the three months ended September 30, 2023.

Related Party Interest Expense, Net

Related party interest expense, net was $23 thousand for the three months ended September 30, 2024 compared to related party interest expense, net of $5 thousand for the three months ended September 30, 2023.

Foreign Exchange Losses (Gains), net

Foreign exchange losses were $0.7 million for the three months ended September 30, 2024 compared to foreign exchange gains of $0.5 million for the three months ended September 30, 2023, primarily due to a higher unrealized exchange losses for the three months ended September 30, 2024 compared to the three months ended September 30, 2023.

Changes in fair value of warrant liability

The change in fair value of warrant liability during the three months ended September 30, 2024 was a gain of $5 thousand. The change in fair value of warrant liability resulted from the remeasurement of the Private Warrant liability between June 30, 2024 and the end of the reporting period, September 30, 2024.

Pension Income, net

Pension income, net was $0.4 million for the three months ended September 30, 2024 compared to pension income, net of $0.2 million for the three months ended September 30, 2023. The increase in pension income was primarily due to an increase in pension-related income recorded in the three months ended September 30, 2024.

43

Income Tax Expense

The Company had an income tax expense of $1.7 million for the three months ended September 30, 2024 compared to an income tax expense of $1.0 million for the three months ended September 30, 2023. The increase in the income tax expenses for the current period was primarily due to a remeasurement of existing uncertain tax positions in Germany, partially offset by decline in profitability in the Netherlands and Germany.

Nine months ended September 30, 2024 Compared to Nine months ended September 30, 2023 (US dollars in thousands)

Nine months ended September 30, 

    

2024

    

2023

Revenue:

 

  

 

  

Bills and Payments

$

75,860

$

82,857

Technology

 

31,127

 

33,554

Revenue, net (including related party revenue of $0.2 million and $0.2 million, respectively)

 

106,987

 

116,411

Cost of revenue:

 

 

  

Bills and Payments

 

64,854

 

71,138

Technology

 

13,950

 

14,468

Total cost of revenue (including related party cost of revenue of $0.0 million and $0.1 million, respectively, exclusive of depreciation and amortization)

 

78,804

 

85,606

Selling, general and administrative expenses (exclusive of depreciation and amortization)

 

19,785

 

21,448

Related party expense

 

3,527

 

3,589

Depreciation and amortization

 

2,387

 

2,207

Operating profit

 

2,484

 

3,561

Interest expense, net

 

4,698

 

3,641

Related party interest expense (income), net

 

64

 

(1)

Foreign exchange losses, net

 

2,016

 

405

Changes in fair value of warrant liability

(45)

Pension income, net

 

(1,278)

 

(589)

Net (loss) income before income taxes

 

(2,971)

 

105

Income tax expense

 

2,666

 

1,523

Net loss from continuing operations

$

(5,637)

$

(1,418)

For the purposes of trend analysis, constant currency refers to the prevailing rate of the US dollar against relevant currencies for the nine months ended September 30, 2023.

Revenue

For the nine months ended September 30, 2024, our net revenue on a consolidated basis decreased by $9.4 million, or 8.1%, to $107.0 million (including related party revenue of $0.2 million) from $116.4 million (including related party revenue of $0.2 million) for the nine months ended September 30, 2023. On a constant currency basis, net revenue declined by $10.6 million or 9.2%, offset by the positive impact of foreign currency accounting for $1.2 million or 1.1%.

Bills & Payments and Technology segments constituted 70.9%, and 29.1%, respectively, of our total net revenue for the nine months ended September 30, 2024, compared to 71.2%, and 28.8%, respectively, for the nine months ended September 30, 2023. The revenue changes by reporting segment were as follows:

Bills & Payments — Net revenue attributable to bills and payments segment was $75.9 million for the nine months ended September 30, 2024, compared to $82.9 million for the nine months ended September 30, 2023. The revenue decline of $7.0 million, or 8.4%, is primarily attributable to completion of projects, lower postage, lower

44

volumes and client contract ends, offset by the positive impact of newly won business, some of which is in early stage of ramp. On a constant currency basis, revenue declined by $7.8 million or 9.4%, offset by the positive impact of foreign currency accounting for $0.8 million or 1.0%.

Technology — For the nine months ended September 30, 2024, net revenue attributable to the Technology segment decreased by $2.4 million, or 7.2%, to $31.1 million from $33.5 million for the nine months ended September 30, 2023. The revenue decrease in the Technology segment was largely due to a lower volume of software licenses sold, partially offset by increase in technology implementation and professional services revenue. On a constant currency basis, revenue decreased by $2.8 million or 8.4%, offset by the positive impact of foreign currency accounted for $0.4 million or 1.2%.

Cost of Revenue

For the nine months ended September 30, 2024, the cost of revenue decreased by $6.8 million (including decrease in related party cost of $0.0 million), or 7.9%, compared to the nine months ended September 30, 2023. Total cost of revenue decreased by $7.9 million or 9.2% on a constant currency basis, offset by the negative impact of foreign currency of $1.1 million or 1.2%, when compared to the cost of revenue for the nine months ended September 30, 2023.

In the Bills & Payments segments, the decrease was primarily attributable to reduced cost resulting from completed projects and optimization efforts. Costs to the Bills & Payments segment decreased by $6.3 million, or 8.8%. On a constant currency basis, cost of revenue at Bills & Payments segment declined by $7.2 million or 10.1%, offset by the negative impact of foreign currency accounted for $0.9 million or 1.3%.

The cost of revenue in the Technology segment decreased by $0.5 million, or 3.6%, primarily due to the change in the revenue mix within the Technology segment. On a constant currency basis, cost of revenue at the Technology segment decreased by $0.6 million or 4.6%, offset by the negative impact of foreign currency accounted for $0.1 million or 1.0%.

The marginal increase in cost of revenues as a percent of revenue on a consolidated basis was primarily due to higher ramp cost during the current period. Cost of revenue for the nine months ended September 30, 2024 was 73.7% of revenue compared to 73.5% of revenue for the nine months ended September 30, 2023.

Selling, General and Administrative Expenses

SG&A expenses decreased by $1.6 million, or 7.8%, to $19.8 million for the nine months ended September 30, 2024, compared to $21.4 million for the nine months ended September 30, 2023. The decrease was primarily attributable to cost optimization initiatives, resulting in reduced operating lease and facility expenses for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023. SG&A expenses increased as a percentage of revenue at 18.5% for the nine months ended September 30, 2024 as compared to 18.4% for the nine months ended September 30, 2023.

Related Party Expense

Related party expense was $3.5 million for the nine months ended September 30, 2024 compared to $3.6 million for the nine months ended September 30, 2023. The decrease was primarily driven by the cost optimization initiatives taken during the current period, partially offset by increase in related party service fees.

Depreciation and Amortization

Total depreciation and amortization expense was $2.4 million and $2.2 million for the nine months ended September 30, 2024 and 2023, respectively. The increase in total depreciation and amortization expense by $0.2 million was primarily due to an increase in amortization expense related to outsource contract costs during the nine months ended September 30, 2024.

45

Interest Expense

Interest expense was $4.7 million for the nine months ended September 30, 2024, compared to $3.6 million for the nine months ended September 30, 2023, largely due to higher pension interest cost and an increase in borrowing costs due to an increase in relevant borrowing reference rates during the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023.

Related Party Interest Expense (Income), Net

Related party interest expense, net was less than $0.1 million for the nine months ended September 30, 2024 compared to related party interest income, net of $1 thousand for the nine months ended September 30, 2023.

Foreign Exchange Losses, net

Foreign exchange losses were $2.0 million for the nine months ended September 30, 2024 compared to foreign exchange losses of $0.4 million for the nine months ended September 30, 2023, primarily due to a higher unrealized exchange losses for the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023.

Changes in fair value of warrant liability

The change in fair value of warrant liability during the nine months ended September 30, 2024 was a gain of $45 thousand. The change in fair value of warrant liability resulted from the remeasurement of the Private Warrant liability between December 31, 2023 and the end of the reporting period, September 30, 2024.

Pension Income, net

Pension income, net was $1.3 million for the nine months ended September 30, 2024 compared to pension income, net of $0.6 million for the nine months ended September 30, 2023. The increase in pension income was primarily due to an increase in pension-related income recorded in the nine months ended September 30, 2024.

Income Tax Expense

The Company had an income tax expense of $2.7 million for the nine months ended September 30, 2024 compared to an income tax expense of $1.5 million for the nine months ended September 30, 2023. The increase in the income tax expenses for the current period is higher than the same period last year due to a remeasurement of existing uncertain tax positions in Germany.

Liquidity and Capital Resources

Overview

At September 30, 2024 and December 31, 2023 cash and cash equivalents totaled $7.8 million and $6.5 million, respectively.

The Company currently expects to spend approximately $1.5 to $2.5 million on total capital expenditures and capitalizable contracts set-up cost over the next twelve months. The Company will continue to evaluate additional capital expenditure needs that may arise.

As of September 30, 2024, and in comparison to December 31, 2023, total debt increased by $14.8 million primarily due borrowings under the 2024 Senior Credit Facilities, partially offset by repayments of Revolving Credit Facilities and 2022 Committed Facility Agreement (See “Indebtedness” below).

The Company has utilized COVID-19 relief measures in various European jurisdictions, including permitted deferrals of certain payroll, social security and value added taxes. At the end of the third quarter 2024, the Company paid

46

a significant portion of these deferred payroll taxes, social security and value added taxes. The remaining balance of deferred payroll taxes, social security and value added taxes is expected to be paid by April 2027, or later, as per deferment timeline as established by local laws and regulations.

The Company believes the current cash, cash equivalents and cash flows from financing activities are sufficient to meet the Company’s working capital and capital expenditure requirements for a period of at least twelve months. To the extent existing cash, cash from operations, and amounts available for borrowing are insufficient to fund future activities, the Company may need to raise additional capital. The Company may require funding for a variety of reasons, including, but not limited to, cost overruns for reasons outside of its control and it may experience slower sales than anticipated. If the Company’s current cash on hand is not sufficient to meet its financing requirements for the next twelve months, it may have to raise funds to allow it to continue to operate its business and execute on its business plan. The Company cannot be certain that funding will be available on acceptable terms or at all particularly given the amount of Company securities being offered, the terms of such securities and the potential duration of any offering. To the extent that the Company raises additional funds by issuing equity securities, its stockholders may experience significant dilution. Any debt financing, if available, may involve restrictive covenants that may impact the Company’s ability to conduct business or return capital to investors. If the Company is unable to raise additional capital on acceptable terms, it may have to significantly scale back, delay or discontinue certain businesses, restrict its operations or obtain funds by entering into agreements on unattractive terms.

Cash Flows

Our condensed consolidated statements of cash flows include cash flows related to the disposable group. Significant non-cash items and capital expenditures of discontinued operations related to our disposable group are presented separately in Note 3 - Discontinued Operations of the notes to condensed consolidated financial statements in this Quarterly Report.

The following table summarizes our cash flows for the periods indicated:

Nine months ended September 30, 

(dollars in thousands)

    

2024

    

2023

Net cash provided by (used in) operating activities

 

$

(11,154)

$

1,743

Net cash used in investing activities

(1,441)

 

(2,254)

Net cash provided by (used in) financing activities

14,233

 

(3,938)

Effect of exchange rates on cash and cash equivalents

(583)

 

(205)

Net increase (decrease) in cash and cash equivalents

$

1,055

$

(4,654)

Analysis of Cash Flow Changes between the nine months ended September 30, 2024 and 2023

Operating Activities — Net cash used in operating activities was $11.2 million for the nine months ended September 30, 2024, compared to net cash provided by operating activities of $1.7 million for the nine months ended September 30, 2023. The increase of $12.9 million in cash used in operating activities was largely due to a higher net loss and higher outflows from accrued expenses and other liabilities, and related party payable.

Investing Activities — Net cash used in investing activities was $1.4 million for the nine months ended September 30, 2024, compared to net cash used in investing activities of $2.3 million for the nine months ended September 30, 2023. The decrease of $0.9 million in cash used in investing activities was primarily due to reduction in additions of property, plant and equipment during the nine months ended September 30, 2024.

The cash outflow of $1.4 million in investing activities for the nine months ended September 30, 2024 was primarily due to additions to property, plant and equipment during the period.

Financing Activities — Net cash provided by financing activities was $14.2 million for the nine months ended September 30, 2024, compared to net cash used in financing activities of $3.9 million for the nine months ended September 30, 2023. The increase of $18.1 million in cash provided by financing activities for the nine months ended

47

September 30, 2024 was primarily due to borrowings under the 2024 Senior Credit Facilities, partially offset by repayments of Revolving Credit Facilities and 2022 Committed Facility Agreement, and reduction in net borrowing under the securitization facility due to the entry into the Amended Factoring Agreement on September 15, 2023, which resulted in an off-balance sheet treatment of the Secured Borrowing Facility.

Indebtedness

Secured Borrowing Facility

On August 25, 2020, certain entities entered into an agreement wherein amounts due from clients were pledged to a third party, in exchange for a borrowing facility in amounts up to a total of €31.0 million (the “Secured Borrowing Facility”). The proceeds from the Secured Borrowing Facility were determined by the amounts invoiced to our clients. The amounts due from clients were recorded in accounts receivable and the amount due to the third party as a liability, presented under current portion of long-term debt on the condensed consolidated balance sheets. The cost of the Secured Borrowing Facility was 0.10% of newly assigned receivables with minimum of €0.1 million in annual fees and the Secured Borrowing Facility bore interest at Euribor rate plus 0.70% on the unpaid principal amount. The Company incurred interest expense of $0 and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and $0 and $0.4 million for the nine months ended September 30, 2024 and 2023, respectively, related to the Secured Borrowing Facility. As of September 30, 2024 and December 31, 2023, the outstanding balances payable under the Secured Borrowing Facility were $0 and $0.1 million, respectively.

On September 15, 2023, the relevant entities entered into an amendment to the Secured Borrowing Facility (the “Amended Factoring Agreement”) to convert the existing arrangement into a non-recourse factoring program wherein an unrelated third party (the “Factor”) shall provide financing to certain subsidiaries of the Company by purchase of certain approved and partially approved accounts receivables (as defined in the Amended Factoring Agreement) up to a maximum amount of €15.0 million while assuming the risk of non-payment on the purchased accounts receivables up to the level of approval. The relevant entities shall have no continuing involvement in the transferred accounts receivable, other than collection and administrative responsibilities and, once sold, the accounts receivable shall no longer be available to satisfy creditors of the relevant entities.

The Company accounted for the transactions under the Amended Factoring Agreement as a sale under ASC 860, Transfers and Servicing, and treats it as an off-balance sheet arrangement. Net funds received from the transfers reflect the face value of the account less a fee, which is recorded as an increase to cash and a reduction to accounts receivable outstanding in the condensed consolidated balance sheets. The Company reports the cash flows attributable to the sale of account receivables to the Factor and the cash receipts from collections made on behalf of and paid to the Factor under the Amended Factoring Agreement, on a net basis as trade accounts receivables in cash flows from operating activities in the Company’s condensed consolidated statements of cash flows.

As of September 30, 2024, the Company’s outstanding factored accounts receivable amounted to $9.2 million pursuant to the Amended Factoring Agreement, representing the face value of the invoices. The Company recognizes factoring costs upon disbursement of funds. The Company incurred a loss on sale of accounts receivables including expenses pursuant to the Amended Factoring Agreement totaling approximately $0.3 million and $0.7 million for the three and nine months ended September 30, 2024, respectively, which is presented in selling, general and administrative expenses (exclusive of depreciation and amortization) on the condensed consolidated statements of operations.

2019 Credit Agreement

In October 2019, a wholly-owned UK subsidiary of XBP Europe (the “UK Subsidiary”) entered into a secured credit agreement (the “2019 Credit Agreement”) with HSBC UK Bank plc (“HSBC”) for a £9.0 million Secured Credit Facility (the “Secured Credit Facility”) consisting of (i) a secured Term Loan A facility in an aggregate principal amount of £2.0 million (the “Term Loan A Facility”), (ii) a secured Term Loan B facility in an aggregate principal amount of £2.0 million (the “Term Loan B Facility”), and (iii) a secured revolving credit facility in an aggregate principal amount of £5.0 million (the “Revolving Credit Facility”). On December 21, 2022, the UK Subsidiary

48

amended its 2019 Credit Agreement, allowing the UK Subsidiary to affirm to extend the maturity of Term Loan A Facility and Term Loan B Facility to October 31, 2024 subject to compliance with financial covenants. On February 9, 2023, the UK Subsidiary amended its 2019 Credit Agreement, allowing the UK Subsidiary to extend the maturity of the Revolving Credit Facility to October 31, 2024 subject to compliance with financial covenants. The maturity of the Revolving Credit Facility has since been extended on various dates. On May 10, 2024, the maturity was further extended to August 31, 2025. During the nine months ended September 30, 2024, the Company has repaid outstanding amount of $1.7 million, $0.2 million, and $6.3 million under the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility, respectively and accordingly wrote off the unamortized balance of less than $0.1 million of debt issuance cost related to the 2019 Credit Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2019 Credit Agreement. As of December 31, 2023, the outstanding balance of the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility was $1.9 million, $0.4 million, and $6.4 million, respectively.

The 2019 Credit Agreement contains financial covenants including, but not limited to (a) a Combined Cashflow Coverage Ratio, which measures the ratio of (i) Combined Cashflow and (ii) Debt Service defined as finance charges in addition to mandatory repayments in respect to the 2019 Credit Agreement, (b) Combined Interest Coverage Ratio, which measures the ratio of (i) Combined EBITDA to (ii) Combined Finance Charges, (c) a Combined Total Net Leverage Ratio, which measures the ratio of (i) Combined Net Indebtedness in respect to the last day of the most recent period to (ii) EBITDA, (d) Guaranteed Intragroup Balances, (e) the Loan to Market Value defined as the Facility A Loan outstanding to the market value of the property in each case, as defined in the 2019 Credit Agreement. The term “Combined” refers to the UK Subsidiary and its wholly-owned subsidiaries.

The 2019 Credit Agreement and indenture governing the Secured Credit Facility contains limitations on the ability of the UK subsidiary to effect mergers and change of control events as well as certain other limitations, including limitations on: (i) the declaration and payment of dividends or other restricted payments (ii) substantial changes of the general nature of the business, (iii) acquisition of a company, (iv) enter a joint venture, (v) or effect a dormant subsidiary to commence trading or cease to satisfy the criteria of a dormant subsidiary.

The UK Subsidiary’s obligations under the 2019 Credit Agreement are jointly and severally guaranteed by certain of its existing and future direct and indirectly wholly owned subsidiaries. The 2019 Credit Agreement and the 2022 Committed Facility Agreement (defined below) contain cross default provisions which relate to the UK Subsidiary and its subsidiaries, but not any other entities within the consolidated group.

At inception, borrowings under the Secured Credit Facility bore interest at a rate per annum equal to the LIBOR plus the applicable margin of 2%, 2.5%, and 3% per annum for the Term Loan A Facility, the Term Loan B Facility, and the Revolving Credit Facility respectively. Effective October 29, 2021, borrowings under the Revolving Credit Facility bore interest at a rate per annum equal to the Sterling Overnight Index Average (“SONIA”) plus the applicable margin of 3%. Effective December 31, 2021, borrowings under the Term Loan A Facility and the Term Loan B Facility bore interest at a rate per annum equal to the SONIA plus the applicable margin of 2% and 2.5%, respectively.

In June 2020, the UK Subsidiary entered into an amendment to the 2019 Credit Agreement, to provide an additional aggregate principal amount of £4.0 million under a credit agreement (the “Revolving Working Capital Loan Facility” or “2020 Credit Agreement”) together with Revolving Credit Facility (the “Revolving Credit Facilities”). At the inception of the Revolving Working Capital Loan Facility, the borrowing bore an interest rate per annum equal to the LIBOR plus the applicable margin of 3.5% per annum. Effective March 31, 2023, borrowings under the Revolving Working Capital Loan Facility bore interest at a rate per annum equal to the SONIA plus the applicable margin of 3.5%.

The maturity of the Revolving Working Capital Loan Facility has since been extended on various dates subject to compliance with financial covenants. On May 10, 2024 the maturity was further extended to August 31, 2025. During the nine months ended September 30, 2023, the Company has repaid outstanding amount of $5.1 million under the 2020 Credit Agreement and accordingly wrote off the unamortized balance of less than $0.1 million of debt issuance cost realted to the 2020 Credit Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2020 Credit Agreement. As of December 31, 2023, the Revolving Working Capital Loan Facility had an outstanding principal balance of $5.1 million.

49

As of December 31, 2023, the UK Subsidiary was in compliance with all affirmative and negative covenants under the 2019 Credit Agreement, including any financial covenants, pertaining to its financing arrangements.

2022 Committed Facility Agreement

In May 2022, the UK Subsidiary entered into a committed facility agreement (the “2022 Committed Facility Agreement”) with HSBC, which includes a term loan for £1.4 million to be used in refinancing a property owned by XBP Europe in Dublin, Ireland (the “Property”). At inception of the 2022 Committed Facility Agreement, the borrowing bore an interest rate equal to 3.5% per annum in addition to the Bank of England Base Rate. The maturity of the 2022 Committed Facility Agreement is May 2027. During the nine months ended September 30, 2024, the Company has repaid outstanding amount of $1.4 million under the 2022 Committed Facility Agreement. As of September 30, 2024, the Company had fully repaid the outstanding balance under the 2022 Committed Facility Agreement. As of December 31, 2023, the 2022 Committed Facility Agreement had an outstanding balance of $1.5 million.

The 2022 Committed Facility Agreement contains financial covenants including, but not limited to (a) a Combined Debt Service Coverage Ratio, which measures the cashflow less dividends, net capital expenditure, and taxation relative to the debt service for that relevant period, (b) interest cover, which measures EBITDA relative to the aggregate of (i) interest charges and (ii) interest element of finance leases in any relevant period, (c) Total Net Debt to EBITDA, which measures the total net debt relative to EBITDA for any relevant period, and (d) loan to market value, which measures the loan as a percentage of the aggregate market value of the Property. The term “Combined” refers to the UK subsidiary and its wholly-owned subsidiaries.

As of December 31, 2023, the UK Subsidiary was in compliance with all affirmative and negative covenants under the 2022 Committed Facility Agreement, including any financial covenants pertaining to its financing arrangements.

2024 Facilities Agreement

In June 2024, XBP Europe, Inc. a wholly-owned subsidiary of the Company, together with certain other subsidiaries (the “XBP Group”), entered into a Facilities Agreement (the “2024 Facilities Agreement”) with HSBC UK Bank plc (“HSBC”) for a £15.0 million and €10.5 million Secured Credit Facility consisting of (i) a single draw, secured Term Loan A facility in an aggregate principal amount of £3.0 million (the “2024 Term Loan A Facility”), (ii) a single draw, secured Term Loan B facility in an aggregate principal amount of €10.5 million (the “2024 Term Loan B Facility”, collectively with the 2024 Term Loan A Facility, the “2024 Term Loan Facilities”) and (iii) a multi-draw, multi-currency secured revolving credit facility in an aggregate principal amount of £12.0 million (the “2024 Revolving Credit Facility”), and, together with the 2024 Term Loan Facilities, (the “2024 Senior Credit Facilities”). The 2024 Term Loan Facilities mature on June 26, 2028 and the 2024 Revolving Credit Facility matures on June 26, 2027, with certain extension rights at the discretion of HSBC. An additional £14.0 million of credit under the 2024 Revolving Credit Facility may be made available at HSBC’s discretion for specific purposes as per the 2024 Facilities Agreement.

The Company used the 2024 Term Loan Facilities to repay in full all outstanding indebtedness under the 2019 Credit Agreement, 2020 Credit Agreement and 2022 Committed Facility Agreement. The Company incurred $1.6 million in debt issuance costs related to the 2024 Facilities Agreement.

The 2024 Facilities Agreement contains financial covenants including, but not limited to, (i) requiring the maintenance of a consolidated total leverage ratio of not greater than 2.50 to 1.00 (with step-downs to (a) 2.25 to 1.00 starting January 1, 2025 and (b) 2.00 to 1.00 starting January 1, 2026); (ii) a cash flow coverage ratio of at least 1.10:1.00; and (iii) a consolidated interest coverage ratio of not less than 4.00 to 1.00.

The 2024 Facilities Agreement and indenture governing the 2024 Secured Credit Facilities contains certain affirmative and negative covenants limiting on the ability of the XBP Group to effect mergers and change of control events as well as certain other limitations, including limitations on (i) incurrence of additional indebtedness or liens, (ii) dispositions of assets, (iii) substantial changes of the general nature of the business, (iv) entering into restrictive agreements, (v) making certain investments, loans, advances, guarantees and acquisitions, (vi) prepaying certain

50

indebtedness, (vii) the declaration and payment of dividends or other restricted payments, (viii) engaging in transactions with affiliates, or (ix) amending certain material documents.

Except as otherwise provided by applicable law, all obligations under the 2024 Facilities Agreement are jointly and severally unconditionally guaranteed by each member of the XBP Group.

Borrowings under the 2024 Term Loan A Facility, the 2024 Term Loan B Facility and 2024 Revolving Credit Facility bear interest at a rate per annum equal to the SONIA plus the applicable margin of 3.25%, Euro Interbank Offered Rate (“EURIBOR”) plus the applicable margin of 3.25% and Reference Rate plus the applicable margin of 3.25%, respectively. “Reference Rate” for any period means (i) Secured Overnight Financing Rate (“SOFR”) for funds extended in U.S. Dollars; (ii) the EURIBOR, for funds extended in Euros; (iii) the SONIA, for funds extended in Pounds Sterling; and the Stockholm Interbank Offered Rate (“STIBOR”) for funds extended in Swedish Krona.

During the nine months ended September 30, 2024, the Company has drawn $3.9 million under 2024 Term Loan A Facility and $11.4 million under 2024 Term Loan B Facility, and repaid $8.2 million outstanding indebtedness under the 2019 Credit Agreement, $5.1 million outstanding indebtedness under the 2020 Credit Agreement and $1.4 million outstanding indebtedness under the 2022 Committed Facility Agreement. Accordingly, the Company wrote off the unamortized balance of less than $0.1 million of debt issuance costs related to the 2019 Credit Agreement and 2020 Credit Agreement.

During the three and nine months ended September 30, 2024, the Company repaid $0.2 million and $0.6 million of outstanding principal amount under the 2024 Term Loan A Facility and 2024 Term Loan B Facility, respectively. As of September 30, 2024, the outstanding balance of the 2024 Term Loan A Facility and the 2024 Term Loan B Facility was $3.8 million and $11.1 million, respectively. The principal amount drawn under the 2024 Term Loan A Facility shall be repaid in fifteen (15) equal quarterly installments of £150 thousands with the remaining outstanding principal amount of £750 thousands payable at maturity along with accrued and unpaid interest. The principal amount drawn under the 2024 Term Loan B Facility shall be repaid in fifteen (15) equal quarterly installments of €525 thousands with the remaining outstanding principal amount of €2.625 million payable at maturity along with accrued and unpaid interest.

As of September 30, 2024, the Company has drawn £12.0 million under 2024 Revolving Credit Facility in Euros currency. As of September 30, 2024, the outstanding balance under the 2024 Revolving Credit Facility was $15.8 million.

The Company may, at any time, prepay the principal of the 2024 Senior Credit Facilities. Each prepayment shall be accompanied by the payment of accrued interest, without any premium or penalty. However, the Company is limited to a maximum of four voluntary prepayments of the 2024 Revolving Credit Facility within any consecutive twelve-month period.

As of September 30, 2024, the XBP Group was in compliance with all affirmative and negative covenants under the 2024 Facilities Agreement, including any financial covenants, pertaining to its financing arrangements. The Company continually monitors its compliance with such covenants. The Company believes it will remain in compliance with all such covenants for the next twelve months; however, due to the inherent uncertainty, management’s estimates of the achievement of its financial covenants may change in the future.

Restructuring Activities

In the fourth quarter of 2023, the Company’s management approved a restructuring plan to realign the Company’s business and strategic priorities by rightsizing its workforce in certain regions. Costs and liabilities associated with management-approved restructuring activities are recognized when they are incurred. One-time employee termination costs are recognized at the time of communication to employees, unless future service is required, in which case the costs are recognized ratably over the future service period. Ongoing employee termination benefits are recognized as a liability when it is probable that a liability exists and the amount is reasonably estimable. Restructuring charges are recognized as an operating expense within the consolidated statements of operations for the year ended

51

December 31, 2023 and related liabilities are recorded within accrued compensation and benefits on the consolidated balance sheets as of December 31, 2023. The Company periodically evaluates and, if necessary, adjusts its estimates based on currently available information.

Potential Future Transactions

We may, from time to time, explore and evaluate possible strategic transactions, which may include joint ventures, as well as business combinations or the acquisition or disposition of assets. In order to pursue certain of these opportunities, additional funds will likely be required. Subject to applicable contractual restrictions, to obtain such financing, we may seek to use cash on hand, or we may seek to raise additional debt or equity financing through private placements or through underwritten offerings. There can be no assurance that we will enter into additional strategic transactions or alliances, nor do we know if we will be able to obtain the necessary financing for transactions that require additional funds on favorable terms, if at all. In addition, pursuant to the Registration Rights Agreement that we entered into in connection with the closing of the Business Combination, certain of our stockholders have the right to demand underwritten offerings of our Common Stock. We may from time to time in the future explore, with certain of those stockholders the possibility of an underwritten public offering of our Common Stock held by those stockholders. There can be no assurance as to whether or when an offering may be commenced or completed, or as to the actual size or terms of the offering.

Critical Accounting Estimates

The preparation of financial statements requires the use of judgments and estimates. The critical accounting policies provide a better understanding of how the Company develops its assumptions and judgments about future events and related estimations and how they can impact the Company’s financial statements. A critical accounting estimate is one that requires subjective or complex estimates and assessments and is fundamental to the Company’s results of operations. The Company bases its estimates on historical experience and on various other assumptions it believes to be reasonable according to the current facts and circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company believes the current assumptions, judgments and estimates used to determine amounts reflected in the condensed consolidated financial statements are appropriate; however, actual results may differ under different conditions. This discussion and analysis should be read in conjunction with the Company’s condensed consolidated financial statements and related notes included elsewhere in this report. This discussion and analysis should be read in conjunction with the Company’s financial statements and related notes included elsewhere in this report. Refer to "Critical Accounting Estimates" contained in Part II, Item 7 of our 2023 Form 10-K for a complete discussion of critical accounting estimates. There have been no material changes to 2023 Form 10-K.

Emerging Growth Company Status

The Jumpstart our Business Startups Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable.

The Company is an “emerging growth company” as defined in Section 2(a) of the Securities Act and has elected to take advantage of the benefits of the extended transition period for new or revised financial accounting standards, although it may decide to early adopt such new or revised accounting standards to the extent permitted by such standards. This may make it difficult or impossible to compare the Company’s financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used.

52

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

Quantitative and Qualitative Disclosure About Market Risk

There have been no material changes to the Company’s market risk during the nine months ended September 30, 2024. For a discussion of the Company’s exposure to market risk, refer to the Company’s market risk disclosures set forth in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of the 2023 Form 10-K.

ITEM 4.   CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”) has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2024. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and our management necessarily applies its judgement in evaluating the cost-benefit relationship of possible controls and procedures. Based on such review and evaluation, our CEO and our CFO have concluded that as of September 30, 2024, our internal controls were not effective due to material weaknesses identified. The material weakness identified related to ineffective review controls over the financial statement closing process and order-to cash process including the review of new agreements and work orders.

In light of these material weaknesses and subsequent to the recent completion of the Business Combination, we have enhanced our review controls, added experienced people across order to cash sub-processes for managing critical control activities, and rationalized the controls framework to remove duplicate and redundant controls. We have also established a Center of Excellence (COE) by consolidating financial processes to strengthen the controls framework. The COE’s mission is to create appropriate finance structures, formalize lines of reporting and appoint competent personnel with defined roles and responsibilities to strengthen internal controls. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. We believe our efforts will enhance our controls relating to financial reporting, but we can offer no assurance that our controls will not require additional review and modification in the future as industry accounting practice may evolve over time.

Notwithstanding such material weaknesses in internal control over financial reporting, our management, including our CEO and CFO, has concluded that our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023, and the condensed consolidated statements of operations, comprehensive loss and stockholders’ deficit for each of the three and nine months ended September 30, 2024 and September 30, 2023, and condensed consolidated statements of cash flows for each of the nine months ended September 30, 2024 and September 30, 2023, present fairly, in all material respects, our financial position, results of our operations and our cash flows for the periods presented in this Annual Report, in conformity with U.S. GAAP.

53

Changes in Internal Controls over Financial Reporting

Other than as disclosed above, there was no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended September 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

Subsidiary Litigation

A group of 71 former employees brought a claim against a subsidiary of the Company related to their dismissal resulting from the closure of two production sites in France in 2020. The employees filed complaints with the Labor Court on June 9, 2022. Conciliation hearings at the Labor Court were held on September 27, 2022, December 13, 2022, March 7, 2023, September 5, 2023 and November 14, 2023.

In March 2023, 67 claimants (after the in principle settlement was agreed with the first 4 claimants) filed an application for summary proceedings in respect of part of the claim for a total claim of $1.1 million. The summary proceedings hearing was held on April 11, 2023 and the court issued its decision on May 9, 2023 upholding all of the plaintiffs’ claims for a total amount of $1.1 million, however the court’s decision does not increase the Company’s anticipated exposure for the overall claim. The Company has appealed against the decision (and paid the amount of $1.1 million on November 10, 2023 pending the appeal), the appeal hearing was scheduled for September 9, 2024 and was held on November 4, 2024. The next hearing, pertaining only to 15 remaining claimants who have not concluded settlement agreements with the Company, is scheduled for January 13, 2025.

The substantive hearing was held on February 16, 2024 and a decision was made at the end of June 2024. 

The Company reached a number of settlements with a certain number of claimants prior to the decision of the court and approximately $1.8 million was paid to such claimants in addition to the amounts paid as part of the summary proceedings. The court awarded $1.2 million to the claimants who had not settled before the court’s decision and, after the deduction of the amounts already paid to such claimants, $1.0 million remain to be paid by the Company. The Company will also be responsible for up to three months’ unemployment allowance paid to these claimants by the unemployment fund, which is not expected to significantly increase the Company’s total costs. The Company has appealed the decision. The Company accrued $1.1 million and $2.2 million in accrued liabilities on the condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023, respectively, based on the estimate of the range of possible losses.

Other

We are, from time to time, involved in other legal proceedings, inquiries, claims and disputes, which arise in the ordinary course of business. Although our management cannot predict the outcomes of these matters, our management believes these actions will not have a material, adverse effect on our financial position, results of operations or cash flows.

ITEM 1A.  RISK FACTORS

In addition to the other information set forth in this quarterly report, you should carefully consider the risk factors described in Part I, “Item 1A. Risk Factors” in the 2023 Form 10-K, which could materially affect our business, financial condition and/or operating results. The risks described in those Risk Factors are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

54

ITEM 2.  UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable

ITEM 5.   OTHER INFORMATION

(c) Director and Officer Trading Arrangements

During the nine-month period ended September 30, 2024, none of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.

55

PART IV

ITEM 6.   EXHIBITS

Exhibit No.

    

Description

31.1*

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

* Filed or furnished herewith, as applicable.

56

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:

By:

/s/ Andrej Jonovic

November 12, 2024

Andrej Jonovic, Chief Executive Officer

(Principal Executive Officer)

Dated:

By:

/s/ Dejan Avramovic

November 12, 2024

Dejan Avramovic, Chief Financial Officer

(Principal Financial and Accounting Officer)

57

Exhibit 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Andrej Jonovic, certify that:

1.    I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2024 of XBP Europe Holdings, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 12, 2024

By:

/s/ Andrej Jonovic

 

 

Andrej Jonovic

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)


Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dejan Avramovic, certify that:

1.     I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2024 of XBP Europe Holdings, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 12, 2024

By:

/s/ Dejan Avramovic

Dejan Avramovic

Chief Financial Officer

(Principal Financial and Accounting Officer)


Exhibit 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of XBP Europe Holdings, Inc. (the “Company”) for the period ended September 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Andrej Jonovic, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.     the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.     the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 12, 2024

By:

/s/ Andrej Jonovic

 

 

Andrej Jonovic

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)


Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of XBP Europe Holdings, Inc. (the “Company”) for the period ended September 30, 2024, as filed with the Securities and Exchange Commission (the “Report”), I, Dejan Avramovic, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: November 12, 2024

By:

/s/ Dejan Avramovic

 

 

Dejan Avramovic

 

 

Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)